ctri data base india icmr
TRANSCRIPT
Clinical trial registry database India/WHO
1 Trial 1 Completed
2 Trial 2
3 Trial 3 Completed
4 Trial 4
5 Trial 5 Completed
6 Trial 6
7 Trial 7
8 Trial 8 Completed
9 Trial 9
S. no
Trial No.
UTRN.WHO CTRI No.and Date
Status of TrialWHO
TEMP UTRN 110920818-21122008400346
CTRI/2008/091/000298, 27-05-2009
TEMP UTRN 084547349-070120101616999
CTRI/2010/091/000016, 13-01-2010
Open to recruitment
TEMP UTRN 013618768-27082008248338
CTRI/2008/091/000154, 12-06-2009
TEMP UTRN 033922579-12022009483602
CTRI/2009/091/000066, 09-03-2009
Open to recruitment
TEMP UTRN 023324110-21032009531943
CTRI/2009/091/000111, 13-05-2009
TEMP UTRN 095106093-15012009436721
CTRI/2009/091/000022, 18-06-2009
Open to recruitment
TEMP UTRN 065751749-0701201016201816
CTRI/2010/091/000020, 01-02-2010
Closed to recruitment of participants
TEMP UTRN 085037996-09012010162852
CTRI/2010/091/000028, 15-01-2010
TEMP UTRN 110121271-09012010162952
CTRI/2010/091/000029, 23-04-2010
Closed to recruitment of participants
10 Trial 10
11 Trial 11
12 Trial 12
13 Trial 13
14 Trial 14
15 Trial 15
16 Trial 16
17 Trial 17
18 Trial 18
19 Trial 19
20 Trial 20
TEMP UTRN 115252025-09012010163152
CTRI/2010/091/000031, 23-04-2010
Closed to recruitment of participants
TEMP UTRN 080354168-231220091572599
CTRI/2009/091/001071, 11-05-2010
Open to recruitment
TEMP UTRN 122452186-10102008301599
CTRI/2008/091/000204, 11-02-2009
Open to recruitment
TEMP UTRN 035051948-16042009602241
CTRI/2009/091/000182, 13-05-2009
Open to recruitment
TEMP UTRN 053105122-16042009603241
CTRI/2009/091/000183, 13-05-2009
Open to recruitment
TEMP UTRN 061806049-16042009604241
CTRI/2009/091/000184, 13-05-2009
Open to recruitment
TEMP UTRN 033519060-150520097221180
CTRI/2009/091/000279, 27-05-2009
Open to recruitment
TEMP UTRN 111634368-1904201020223272
CTRI/2010/091/000401, 30-04-2010
Open to recruitment
TEMP UTRN 105647370-2112200757179
CTRI/2007/091/000043, 28-04-2008
Open to recruitment
TEMP UTRN 111501559-22042008122327
CTRI/2008/091/000047, 30-04-2008
Not yet recruiting
TEMP UTRN 060332551-0801201016251569
CTRI/2010/091/000025, 09-07-2010
Open to recruitment
21 Trial 21
22 Trial 22
23
24
25
26
27
28
29
30
31
TEMP UTRN 060355560-0801201016261569
CTRI/2010/091/000026, 10-03-2010
Open to recruitment
TEMP UTRN 033138488-100720102402235
CTRI/2010/091/001098, 13-07-2010
Not yet recruiting
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
Clinical trial registry database India/WHO
5/27/2009 4/8/2010
1/13/2010 3/26/2010
acute renal failure
6/12/2009 12/23/2009
3/9/2009 4/23/2009
5/13/2009 3/18/2010
6/18/2009 6/24/2010 Septic Shock
2/1/2010 2/1/2010 H1N1
1/15/2010 4/19/2010 H1N1
1/1/2007 5/13/2010 H1N1
Last Verified on
Last Updated on
Speciality-Subspeciality
Congestive heart failure
Chronic Obstructive
Pulmonary Disease
Chronic Obstructive
Pulmonary Disease
Chronic Obstructive
Pulmonary Disease
4/23/2010 5/13/2010 H1N1
5/11/2010 5/5/2010 Shock
2/11/2009 2/11/2009
5/13/2009 5/15/2009
1/1/2007 5/13/2009
5/13/2009 4/27/2009
5/27/2009 5/26/2009
4/30/2010 6/14/2010
4/28/2008 5/20/2010
4/30/2008 1/1/2007
1/1/2007 7/9/2010
cardiac arrhythmias
Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension
life-threatening illness
life-threatening illness
life-threatening illness
3/10/2010 3/5/2010
7/13/2010 7/13/2010
life-threatening illness
life-threatening illness
Public Title StudyWHO* Scientific Title of StudyWHO*
28
31
200
1696
100
72
360
T. sample
size
Cardiac rehabilitation and quality of life in congestive heart failure
The effects of exercise based cardiac rehabilitation on quality of life in
congestive heart failure
A clinical trial to study the effects of a drug, Gammaplex, in patients
with chronic Idiopathic Thrombocytopenic Purpura
A Phase III, Multicenter, Open-Label Study To Evaluate the Efficacy and
Safety of GAMMAPLEX® in Chronic Idiopathic
Study to assess efficacy & safety of doxofylline 400 mg twice daily
versus doxofylline 800 mg ER once daily in the treatment of
A open-labelled, prospective, randomized, two-arm, parallel group
4-week clinical study to assess efficacy & safety of doxophylline
Efficacy and Safety of Indacaterol in Adults (40 Years and Above)
With Chronic Obstructive Pulmonary Disease (COPD)
A Phase III, 26-Week Multi-Center Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study to
Assess the Efficacy, Safety and A clinical trial to study the effects
of two drugs, fixed dose combination of Formoterol
fumarate & Mometasone furoate
An open label, comparative, multicentric study to assess the
efficacy and safety of fixed-dose combination of Formoterol fumarate
Efficacy and Safety of Drotrecogin Alfa (Activated) in
Adult Patients with Septic Shock
A Randomized, Double-blind, Placebo-controlled, Multicenter,
Phase 3 Study of Drotrecogin Alfa (Activated) Administered as a
Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted
Vaccine in Healthy Adults in India
Bridging Study on Safety and Immunogenicity of an Intramuscular
Inactivated, Split Virion Swine-Origin A/H1N1 Influenza Non-
A clinical study to Evaluate The Safety, Tolerability And
Immunogenicity Of Three Formulations (15µg Without
A Randomized, Double Blind, Comparative, Phase I Study To
Evaluate The Safety, Tolerability And Immunogenicity Of Three
A Phase II/III clinical Study to Evaluate the Immunogenicity and Safety of Three Formulations of Monovalent H1N1 Influenza A
A Randomized, Double Blind, Comparative, Phase II/III Study to Evaluate the Immunogenicity and Safety of Three Formulations [15
360
3000
2000
180
180
72
200
180
500
A Phase II/III clinical Study to Evaluate the Immunogenicity and Safety of Three Formulations of Monovalent H1N1 Influenza A
A Randomized, Double Blind, Comparative, Phase II/III Study to Evaluate the Immunogenicity and Safety of Three Formulations [15
Medtronic- Shock-Less study to determine whether periodic
reports delivered to study centers can increase use of shock
Shock-Less study: A prospective, non-randomized, multi-centre post
market clinical trial.
PANARM HF : A clinical registry to understand the disease profiles
of patients who suffer from cardiac arrhythmias and/or heart
PANARM HF -A prospective, multi-center, non-interventional to collect
(at the referring physician stage), data pertaining to the demographic,
SR-PAAS - Sitaxentan Efficacy and Safety Trial With a
Randomized Prospective Assessment of Adding Sildenafil
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-
Controlled, Safety And Efficacy Study Of Sitaxsentan Sodium In
Open-Label Study Providing Monotherapy (Sitaxsentan) and
Combination Therapy (Sitaxsentan+Sildenafil) to
A Phase 3, Multi-Center, Open Label Study To Evaluate The Long-Term Safety Of Monotherapy Sitaxsentan Sodium And Combination Therapy
Study Looking at Combination Therapy (Sitaxsentan+Sildenafil)
vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxentan
A Phase 3, Multi-Center, Randomized, Double-Blind, Efficacy And Safety Study Of Monotherapy
Sitaxsentan Sodium Versus A Research Study To Assess The
Effectiveness And Safety Of Different Doses Of Oral PF-
00489791 In The Treatment Of
A Phase 2a, Randomized, Double Blind, Placebo-Controlled, Parallel
Group Study Investigating The Dose-Response Of PF-00489791 On Acute
An open label clinical trial to study the effects of long term
administration of study drug to Improve Clinical Outcome in
Long term single-arm open label extension study of the SERAPHIN
study to assess the safety and tolerability of ACT-064992 in
Approx 699
A study to determine the safety and activity of a novel oral agent, AV-951, in patients with kidney cancer To determine the safety
A Phase 2, Placebo-Controlled, Randomized, Discontinuation Trial of AV-951 in Patients With Renal Cell
Carcinoma A clinical trial to study the effects
of 2 Ayurvedic formulations, containing Ashwagandha, Brahmi and Amalaki on the physical and
A Proof of Concept prospective, double-blind, placebo controlled, comparative, randomized, parallel
group, multi-centric clinical study to An Extension Treatment Protocol
for Subjects who have Participated in AV-951-09-301
study
An Extension Treatment Protocol for Subjects who have Participated in a
Phase 3 Study of Tivozanib vs. Sorafenib in Renal Cell Carcinoma
500
900
A Clinical Trial Study to Compare Tivozanib to Sorafenib in Subjects
With advanced Renal Cell Carcinoma
A Phase 3, Randomized, Controlled, Multi-Center, Open-Label Study to Compare Tivozanib (AV-951) to
Sorafenib in Subjects With Advanced A clinical trial to study the effects
of a new drug and compare the effect of BIBW 2992 along with
paclitaxel and investgators choice
Phase III randomized trial of BIBW 2992 plus weekly paclitaxel versus
Investigator?s choice of chemotherapy following BIBW 2992
Phase Site 1 Site 2 Site 3 Site 4
1
Phase 3 10
Phase 4 1
Phase 3 2
Phase 3 5
Phase 3 15
Phase 3 3
Phase 1 1
7
Esti trial duration
total Sites no
Not Applicable
1 Years Department of physiotherapy
2 Years
Months Government Medical College & Hospital
Months HEALTH AND RESEARCH CENTRE
SDS Tuberculosis and
Chest & TB Hospital
Mahatma Gandhi Nationa
ASHRAI ASSOCIATES,
Indore Chest Centre, Indore
4 Years Grant Medical Foundation, Ruby Hall
Deenanath Mangeshkar
KEM Hospital & Researc
Dept. of Pulmonary and Critical
12 Months Post Graduate Institute of Medical Education
Department of Pediatrics
Professor and Head, Pediatri
85 Days Fortis Clinical Research Ltd
Phase 2/Phase 3
95 Days ICH (Institute of Child Health)
GR Medical College
G.S.V.M College
Dr.D.Y.Patil Medical College
7
Phase 4 6
8
Phase 3 5
Phase 3 5
Phase 3 5
Phase 2 3
Phase 3 6
Phase 2 5
Phase 2 4
Phase 3 12
Phase 2/Phase 3
95 Days M.G.M Medical College and Chacha
GR Medical College
Dr. Ritabrata Kundu
G.S.V.M College
4 Years Max Devki Devi Heart & Vascular Institute
Max Balaji Hospital
Sri Chitra Insitute for
Escorts Heart Institute &
Not Applicable
2 Years C-4/3 Vasant Vihar
Escort Heart & Research
Heart Care Clinic
Fortis Escorts Hospital
Months Meenakshi Mission Hospital and Research
The Heart Care Clinic
Poona Hospital & Researc
Heart First Cardiac And
58 Months Kovai Medical Center and Hospital
Meenakshi Mission Hospita
The Heart Care Clinic
Poona Hospital & Researc
27 Months Kovai Medical Center and Hospital
Meenakshi Mission Hospita
The Heart Care Clinic
Poona Hospital & Researc
8 Months Bankers Heart Institute
Department Of Cardiology, Sri
Department Of Cardiology,
4.5 Years KEM Hospital & Seth G.S. Medical
G. B. Pant Hospital
P.D Hinduja National
Deenanath Mangeshkar
2 Years Jaslok Hospital & Research Centre
Rajiv Gandhi Cancer Institute
Christian Medical College
Dept. of Oncology, Tata Memori
12 Months TNMC & BYL Nair Hospital, Mumbai
Seth G.S. Medical College
Deccan College of Medical
Vydehi Institute of Medical
2 Years Rajiv Gandhi Cancer Institute and Research
Searoc Cancer Centre,
Shyam Hematology- Oncolo
Mehdi Nawaz Jung insitute,
Phase 3 12
Phase 3 5
2 Years Rajiv Gandhi Cancer Institute and Research
Searoc Cancer Centre,
Shyam Hematology- Oncolo
Mehdi Nawaz Jung insitute,
2 Years Grant Medical Foundation
Tata Memorial Hospita
Dr. Kamakshi Memori
Bhagwan Mahaveer
Site 5 Site 6 Site 7 Site 8 Site 9 Site 10
L.T.M. Medical College &
L.T.M. Medical College &
Narayana Hrudayalaya
Escorts Heart Institute &
Indraprashtha Apollo Hospita
Apollo Hospitals
Dept. of Anaesthesiology,
Mediciti Hospital, 5-9-
M.G.M Medical College and
Sant Dnyaneshwar Medical
K.C General Hospital
Dr.D.Y.Patil Medical College
Sant Dnyaneshwar Medical
K.C General Hospital
Medanta Heart Institute,
Postgraduate Institute of
Fortis Hospital, Mohali
Escorts Hospital & Researc
Escorts Hospital
Indraprastha Apollo Hosp
Kovai Medical Center and Heart First Cardiac And Heart First Cardiac And
Care Hospital
Apollo Hospital Internat
Orchid Nursing Home
Christian Medical College
Orchid Nursing home
Shatabdi Superspeciality
Deenanth Mangeshkar
Chatrapati Shahuji Maharaj
Oyster and Pearl hospital
Mahavir Cancer Sanstha
S.M.S Medical College &
Christian Medical College
Orchid Nursing home
Shatabdi Superspeciality
Deenanth Mangeshkar
Chatrapati Shahuji Maharaj
Oyster and Pearl hospital
Mahavir Cancer Sanstha
S.M.S Medical College &
Kota Cancer Hospital and
Clinical trial registry database India/WHO
1 Trial 1 2/6/2009 2/4/2009
2 Trial 2 9/24/2009 7/27/2009
3 Trial 3 1/13/2010 5/25/2010
4 Trial 4 6/28/2010 6/24/2010
5 Trial 5 6/25/2010 5/19/2010
6 Trial 6 5/20/2010 5/18/2010
7 Trial 7 5/24/2010 5/24/2010
8 Trial 8 6/28/2010 7/20/2010
9 Trial 9
S. no
Trial No.
UTRN.WHO CTRI No.and
Date
Status of
TrialWHO
Last Verified on
Last Updated on
TEMP UTRN 112432317-
15112008348703
CTRI/2008/091/000250, 06-
02-2009
Completed
TEMP UTRN 071031378-
13022009485959
CTRI/2009/091/000068, 24-
09-2009
Completed
TEMP UTRN 030230946-
0601201016142252
CTRI/2010/091/000014, 13-
01-2010
Open to recruitment
TEMP UTRN 012958774-
2601201016942821
CTRI/2010/091/000090, 28-
06-2010
Not yet recruiti
ng
TEMP UTRN 061437776-
1703201018803114
CTRI/2010/091/000264, 25-
06-2010
Open to recruitment
TEMP UTRN 034608176-
0903201018463090
CTRI/2010/091/000231, 20-
05-2010
Open to recruitment
TEMP UTRN 011854564-
1404201020043393
CTRI/2010/091/000383, 24-
05-2010
Not yet recruiti
ng
TEMP UTRN 124004469-
2304201020391247
CTRI/2010/091/000417, 28-
06-2010
Open to recruitment
10 Trial 10
11 Trial 11
12 Trial 12
13 Trial 13
14 Trial 14
15 Trial 15
16 Trial 16
17 Trial 17
18 Trial 18
19 Trial 19
20 Trial 20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
Clinical trial registry database India/WHO
Public Title StudyWHO* Phase
Nephro 25 Phase 4
Nephro 86
Nephro 50 Phase 2
Nephro 100
Nephro 20
Nephro 50
Nephro 50 Phase 4
Nephro 350 Phase 3
Speciality-Subspecialit
y
Scientific Title of StudyWHO*
T. sample
size
OPTIMIZATION OF MYCOPHENOLIC ACID TREATMENT IN RENAL TRANSPLANT RECIPIENTS
PLASMA LEVEL MONITORING OF MYCOPHENOLIC ACID IN RENAL TRANSPLANT RECIPIENTS
"The effectiveness of a behavioral change communication model in promoting physical activity among females with typeII
"The effectiveness of a behavioral change communication model in promoting physical activity among females with typeII
Phase 2/Phase
3
Effects of strength training in patients undergoing dialysis on biochemical parameters, functional capacity and quality of life.
Impact of short term structured Progressive Resistance Training (PRT) in intradialytic patients (DiaPRE study) in the improvement of small solute clearance,
A clinical trial to study the effect of n-acetylcysteine on endothelial dysfunction,oxidative stress and carotid artery intimal
Effect of N-Acetylcysteine on Oxidative Stress, Endothelial Dysfunction and Carotid Artery Intimal Thickness in Chronic Peritoneal Dialysis
Not Applicabl
e
To study the effect of tacrolimus in patients with lupus nephritis
Tacrolimus as induction therapy for proliferative lupus nephritis
Not Applicabl
e
Comparison of efficacy of Tacrolimus versus Cyclophosphamide in Idiopathic Membranous Nephropathy
Comparison of efficacy of Tacrolimus versus Cyclophosphamide in Idiopathic Membranous Nephropathy
Not Applicabl
e
A clinical trial to compare two protein supplements, egg protein and whey protein in dialysis patients.
Comparison of egg protein vs. whey protein supplements in dialysis patients.
Research Study to demonstrate that intravenous iron isomaltoside 1000 (Monofer®) is non-inferior to
A Phase III, Randomized, Comparative, Open-label Study of Intravenous Iron Isomaltoside 1000 (Monofer®) administered by
Site 1 Site 2 Site 3 Site 4 Site 5 Site 6 Site 7
1
1
1
1
1 AIIMS
1 AIIMS
1
10
Esti trial
duration
total Sites no
1.5 Years
Department of
Pharmacology and
Nephrology4 Months Diabetic
clinic OP,Thiruvananthap
uram medical 3 Years Dialysis
Unit, Central Referral Hospital
12 Months
Dept. of nephrolog
y
6 Months
1 Years
6 Months Aditya Birla
Memorial Hospital
17 Months
Pushpawati
Singhania Research Institute
S.K. Soni Hospital
MAMC College,
Lok Nayak
Hospital
Deenanath Mangeshkar Hospital & Research
P. D. Hinduja National Hospital and Research
Apex Kidney Care Pvt Ltd,
Krishna Institute of Medical Sciences
Site 8 Site 9 PhaseSite 10
T. sample size
Esti trial duration
Department of Nephrology,Osmania General Hospital
Muljibhai Patel Urological Hospital, Dr. Virendra
Department of Nephrology,SMS Medical College
Clinical trial registry database India/WHO
S. no CTRI No.and Date Status of TrialWHO
1 Trial 1
2 Trial 2 Open to recruitment
3 Trial 3 Open to recruitment
4 Trial 4 Open to recruitment
5 Trial 5
6 Trial 6 Completed
7 Trial 7
8 Trial 8 Open to recruitment
9 Trial 9 Completed
Trial No. UTRN.WHO
TEMP UTRN 034131515-
030920071653
CTRI/2007/091/000013, 23-
11-2007
Closed to recruitment follow up continuing &
closed to recruitment follow up complete
TEMP UTRN 045105887-
1607200910291247
CTRI/2009/091/000566, 14-
09-2009
TEMP UTRN 024422692-
030220088248
CTRI/2008/091/000016, 16-
09-2008
TEMP UTRN 011412431-
1303200898187
CTRI/2008/091/000028, 11-
04-2008
TEMP UTRN 083206140-
1503200899280
CTRI/2008/091/000029, 30-
05-2008
Closed to recruitment of participants
TEMP UTRN 100645310-
16042008118313
CTRI/2008/091/000043, 23-
04-2008
TEMP UTRN 042145762-
18042008120146
CTRI/2008/091/000045, 30-
04-2008
Closed to recruitment of participants
TEMP UTRN 025944501-
30042008131146
CTRI/2008/091/000056, 13-
05-2008
TEMP UTRN 110711022-
23072008211450
CTRI/2008/091/000117, 18-
08-2008
10 Trial 10
11 Trial 11 Open to recruitment
12 Trial 12 Open to recruitment
13 Trial 13 Open to recruitment
14 Trial 14
15 Trial 15 Completed
16 Trial 16 Open to recruitment
17 Trial 17 Open to recruitment
18 Trial 18 Open to recruitment
19 Trial 19 Not yet recruiting
TEMP UTRN 020611453-
13082008222154
CTRI/2008/091/000128, 21-
08-2008
Closed to recruitment of participants
TEMP UTRN 121809974-
02092008253191
CTRI/2009/091/000159, 30-
04-2009
TEMP UTRN 103823171-
06112008333191
CTRI/2008/091/000236, 07-
01-2009
TEMP UTRN 083356504-
10122008377187
CTRI/2008/091/000277, 17-
12-2008
TEMP UTRN 104712413-
12012009430789
CTRI/2009/091/000016, 16-
01-2009
Closed to recruitment of participants
TEMP UTRN 041121912-
15012009441872
CTRI/2009/091/000027, 06-
03-2009
TEMP UTRN 105000976-
19012009446292
CTRI/2009/091/000032, 31-
07-2009
TEMP UTRN 010112594-
0902200947465
CTRI/2009/091/000057, 11-
02-2009
TEMP UTRN 053546631-
19022009490146
CTRI/2009/091/000073, 01-
04-2009
TEMP UTRN 084701251-
24032009535191
CTRI/2009/091/000115, 27-
03-2009
20 Trial 20 Open to recruitment
21 Trial 21 Not yet recruiting
22 Trial 22 Terminated
23 Trial 23 Open to recruitment
24 Trial 24 Open to recruitment
25 Trial 25 Open to recruitment
26 Trial 26 Open to recruitment
27 Trial 27
28 Trial 28
29 Trial 29
TEMP UTRN 043820600-
310320095691134
CTRI/2009/091/000149, 02-
04-2009
TEMP UTRN 032053841-
1604200960153
CTRI/2009/091/000181, 22-
05-2009
TEMP UTRN 031727816-
240420096271032
CTRI/2009/091/000207, 05-
05-2009
TEMP UTRN 044909658-
230420096241220
CTRI/2009/091/000204, 21-
08-2009
TEMP UTRN 022805993-
20052009739179
CTRI/2009/091/000295, 21-
08-2009
TEMP UTRN 095709609-
18052009726422
CTRI/2009/091/000283, 06-
11-2009
TEMP UTRN 115924240-
290420096391230
CTRI/2009/091/000219, 18-
05-2009
TEMP UTRN 115410081-
10062009804721
CTRI/2009/091/000354, 07-
10-2009
Closed to recruitment of participants
TEMP UTRN 062441378-
11052009705804
CTRI/2009/091/000262, 08-
06-2009
Closed to recruitment of participants
TEMP UTRN 041905807-
2707200910571534
CTRI/2009/091/000593, 03-
09-2009
Closed to recruitment of participants
30 Trial 30 Open to recruitment
31 Trial 31 Open to recruitment
32 Trial 32 Terminated
33 Trial 33 Open to recruitment
34 Trial 34 Open to recruitment
35 Trial 35
36 Trial 36
37 Trial 37
38 Trial 38 Completed
39 Trial 39 Open to recruitment
TEMP UTRN 110258934-
20052009737872
CTRI/2009/091/000293, 31-
03-2010
TEMP UTRN 115603120-
300620099401266
CTRI/2009/091/000478, 23-
09-2009
TEMP UTRN 023023778-
120620098121510
CTRI/2009/091/000362, 25-
06-2009
TEMP UTRN 023242988-
170620098321569
CTRI/2009/091/000382, 09-
07-2009
TEMP UTRN 114134924-
230620098811534
CTRI/2009/091/000424, 06-
08-2009
TEMP UTRN 104816397-
300620099391266
CTRI/2009/091/000477, 23-
09-2009
Closed to recruitment of participants
TEMP UTRN 013216120-
240620098991632
CTRI/2009/091/000441, 04-
08-2009
Closed to recruitment of participants
TEMP UTRN 104806323-
020720099581266
CTRI/2009/091/000495, 15-
10-2009
Closed to recruitment of participants
TEMP UTRN 034931413-
060720099791266
CTRI/2009/091/000516, 07-
12-2009
TEMP UTRN 093307396-
07072009984146
CTRI/2009/091/000521, 06-
11-2009
40 Trial 40 Open to recruitment
41 Trial 41 Open to recruitment
42 Trial 42 Not yet recruiting
43 Trial 43 Not yet recruiting
44 Trial 44 Open to recruitment
45 Trial 45 Open to recruitment
46 Trial 46 Open to recruitment
47 Trial 47 Open to recruitment
48 Trial 48 Open to recruitment
49 Trial 49
TEMP UTRN 025654840-
150720091022146
CTRI/2009/091/000559, 14-
09-2009
TEMP UTRN 100055778-
2307200910471854
CTRI/2009/091/000942, 18-
11-2009
TEMP UTRN 110112544-
1108200911031386
CTRI/2009/091/000637, 31-
08-2009
TEMP UTRN 111132892-
1404201020021247
CTRI/2010/091/000381, 12-
07-2010
TEMP UTRN 122022538-
3108200911632037
CTRI/2009/091/000694, 25-
09-2009
TEMP UTRN 104256160-
160920091245191
CTRI/2009/091/000771, 28-
10-2009
TEMP UTRN 113223348-
2309200912671444
CTRI/2009/091/000790, 30-
09-2009
TEMP UTRN 042216998-
23092009127236
CTRI/2009/091/000795, 22-
01-2010
TEMP UTRN 032333861-
2509200912781134
CTRI/2009/091/000800, 14-
10-2009
TEMP UTRN 041442161-
0510200912951772
CTRI/2009/091/000817, 14-
10-2009
Closed to recruitment of participants
50 Trial 50 Open to recruitment
51 Trial 51
52 Trial 52 Open to recruitment
53 Trial 53 Open to recruitment
54 Trial 54 Open to recruitment
55 Trial 55 Not yet recruiting
56 Trial 56 Not yet recruiting
57 Trial 57 Open to recruitment
58 Trial 58 Not yet recruiting
59 Trial 59 Not yet recruiting
TEMP UTRN 105619330-
1410200913411134
CTRI/2009/091/000857, 20-
10-2009
TEMP UTRN 021250245-
211020091359789
CTRI/2009/091/000875, 06-
11-2009
Closed to recruitment of participants
TEMP UTRN 125126374-
301020091377872
CTRI/2009/091/000890, 23-
04-2010
TEMP UTRN 054232650-
0211200913881220
CTRI/2009/091/000900, 19-
11-2009
TEMP UTRN 110004254-
081220091524187
CTRI/2009/091/001024, 19-
03-2010
TEMP UTRN 043107269-
060120101615461
CTRI/2010/091/000015, 17-
02-2010
TEMP UTRN 025907064-
111220091543129
CTRI/2009/091/001042, 15-
12-2009
TEMP UTRN 101233806-
1612200915611134
CTRI/2009/091/001060, 23-
12-2009
TEMP UTRN 111135404-
0902201017471386
CTRI/2010/091/000136, 22-
02-2010
TEMP UTRN 030939207-
220220101790146
CTRI/2010/091/000177, 09-
03-2010
60 Trial 60 Not yet recruiting
61 Trial 61 Open to recruitment
62 Trial 62 Open to recruitment
63 Trial 63 Not yet recruiting
64 Trial 64 Not yet recruiting
65 Trial 65 Open to recruitment
66
67
68
69
TEMP UTRN 112053446-
250220101803146
CTRI/2010/091/000190, 13-
04-2010
TEMP UTRN 041841416-
1903201018941134
CTRI/2010/091/000277, 31-
03-2010
TEMP UTRN 023347243-
2704201020563461
CTRI/2010/091/000433, 26-
05-2010
TEMP UTRN 023429554-
2804201020653458
CTRI/2010/091/000441, 17-
05-2010
TEMP UTRN 031230504-
0806201022371386
CTRI/2010/091/000610, 29-
06-2010
TEMP UTRN 015212606-
2806201023542133
CTRI/2010/091/001052, 12-
07-2010
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
Clinical trial registry database India/WHO
Public Title StudyWHO*
11/9/2008 17-04-2009 Onco
14-02-2009 1/9/2009 Onco
16-09-2008 30-12-2008 Onco
11/4/2008 1/7/2008 Onco
30-05-2008 23-10-2008 Onco
23-04-2008 1/1/2007 Onco
30-04-2008 23-02-2009 Onco
13-05-2008 24-02-2009 Onco
18-08-2008 18-07-2009 Onco
Last Verified on
Last Updated on
Speciality-Subspeciality
.A clinical trial to study the effects, (side effects and efficacy) of two combinations of chemotherapy drugs, (Paclitaxel, ifosfamide and Treatment of patients with Aggressive Lymphoma following Self Stem Cell Transplantation
Phase III Randomized Trial of Maintenance Pegylated Liposomal Doxorubicin (PLD) / Carboplatin versus without in Patients with Advanced A double blind clinical trial comparing the study drug and placebo as second line therapy for treatment of Locally Advanced or Metastatic Non A study to assess the effect of two chemotherapy drugs (paclitaxel and Cisplatin) along with radiation in treating cancer of the uterine cervix Effect of Praneem polyherbal formulations against Infection of HPV in Uterine cervix.
To compare two advanced high-precision radiotherapy techniques in head and neck cancers.
Effect of no head shaving in Neurosurgery on the risk of wound infection
A clinical trial to study the efficacy of probiotic Lactobacillus brevis lozenges in preventing radiation and chemotherapy induced oral
21-08-2008 10/6/2010 Onco
22-09-2008 30-04-2009 Onco
7/1/2009 1/10/2009 Onco
17-12-2008 11/12/2008 Onco
16-01-2009 3/7/2009 Onco
6/3/2009 25-09-2009 Onco
31-07-2009 30-07-2009 Onco
11/2/2009 10/2/2009 Onco
1/4/2009 25-03-2009 Onco
27-03-2009 30-04-2009 Onco
Study of Bavituximab plus Paclitaxel and Carboplatin in patients with Non small Cell Lung Cancer.
A phase II clinical trial to study the efficacy and safety of a new drug P276-00 in treatment of recurrent and/or advanced head and neck cancer A Phase I Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies A Multinational Randomized Double Blind, Placebo-controlled study to evaluate the efficacy and safety of AVE5026 in the prevention of Venous A clinical trial to study the safety and efficacy of ALD518 in patients with non-small cell lung cancer-related fatigue and cachexia. A post marketing study to study the pharmacokinetic parameters of Factor VIII in patients with Haemophilia A
A clinical trial to study the effect of Cetuximab + Folfiri or Cetuximab + Folfox in patients with KRAS wild type metastatic Colorectal Cancer. A Clinical study to evaluate the effect of Combretastatin A-4 Phosphate in Combination With Paclitaxel and Carboplatin in Comparison To compare the efficacy and safety of low-dose versus standard-dose Filgrastim in chemotherapy induced Neutropenia. A clinical trial to study safety and effects of P276-00 in combination with radiation in patients with recurrent and /or locally advanced head and neck
2/4/2009 1/4/2009 Onco
25-05-2009 5/5/2009 Onco
5/5/2009 2/11/2009 Onco
21-08-2009 18-08-2009 Onco
21-08-2009 20-05-2010 Onco
6/11/2009 12/2/2009 Onco
18-05-2009 14-05-2009 Onco
7/10/2009 16-09-2009 Onco
8/6/2009 1/4/2010 Onco
3/9/2009 31-08-2009 Onco
A Phase 1b/2 Trial of AMG 479 or AMG 102 in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive Stage An observational study to see the effect of chemotherapy (docetaxel+platinum)when given prior to surgery/radiotherapy in Locally This study is to evaluate the safety and tolerability of Fluphenazine HCl Monotherapy in patients with Relapsed or Relapsed-and-A clinical trial to study the safety and efficacy of NRC-AN-019 in patients with Chronic Myeloid Leukemia who are not responding or intolerant to A clinical trial to evaluate the safety and efficacy of talaporfin sodium (activated locally using light of a specific wavelength) on liver metastases in patients Study to evaluate the safety and efficacy of TULY (rasburicase) in prevention and treatment of malignancy-associated hyperuricemia A clinical trial to study the effects of Nanoparticle based Paclitaxel drug, which does not contain the solvent cremophor, in advanced breast cancer The purpose of this study is to evaluate the efficacy (disease response) and safety of mapatumumab in combination with bortezomib and Phase 1 safety, efficacy, and pharmacokinetic study of Paclitaxel nano-dispersion injection in subjects with metastatic breast cancer: A A Clinical trial of Investigational Agent in Combination With Paclitaxel in Subjects With Advanced Solid Tumors and Breast Cancer
31-03-2010 16-03-2010 Onco
23-09-2009 2/7/2010 Onco
25-06-2009 25-06-2010 Onco
9/7/2009 1/10/2009 Onco
6/8/2009 30-06-2009 Onco
23-09-2009 21-06-2010 Onco
v04-08-2009 15-12-2009 Onco
15-10-2009 2/7/2010 Onco
v07-12-2009 7/7/2010 Onco
v06-11-2009 1/1/2007 Onco
A clinical phase III trial to study and compare the effects of human Recombinant PTH in post menopausal female with Osteoporosis EGF106708 : Phase-III trial with adjuvant treatment of patients with ErbB2 overexpressing and/or amplified breast cancer who have Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer A Multicenter, Open-Label, Randomized, Phase 2 Study to Evaluate the Efficacy and Safety of NKTR-102 (PEG-Irinotecan) Versus Irinotecan in Study Comparing Bevacizumab + Temsirolimus Vs Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects EGF106903 : Phase-III trial in women with HER2/Erb2 positive primary breast cancer using neoadjuvant chemotherapy. A clinical trial to study the pharmacokinetic comparison of two formulations for Intravenous Infusion of Paclitaxel in Indain Patients EGF105485: Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer VEG105424 : Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, To access the toxicity and efficacy of altered fractionation radiotherapy without chemotherapy in medulloblastoma
14-09-2009 17-08-2009 Onco
18-11-2009 8/6/2010 Onco
31-08-2009 31-08-2009 Onco
12/7/2010 12/7/2010 Onco
25-09-2009 4/2/2010 Onco
28-10-2009 8/1/2010 Onco
30-09-2009 4/3/2010 Onco
22-01-2010 20-04-2010 Onco
14-10-2009 13-10-2009 Onco
14-10-2009 13-10-2009 Onco
Radiation Treatment Of Bladder Cancer With Tomotherapy/ Intensity Modulated Radio Therapy (IMRT) A Study of Neratinib Plus Paclitaxel Versus Trastuzumab Plus Paclitaxel as First-Line Treatment for ErbB-2-Positive Locally Recurrent or Metastatic A bioequivalence study of Capecitabine tablets in patients of Locally Advanced or Metastatic Breast Cancer or Metastatic Colorectal Cancer IY5511 HCL for chronic Myelogenous leukemia
A clinical trial to study the effects of two drugs Peg G-CSF and Grafeel® in the prevention of reduction in neutrophil counts in cancer patients caused A phase II trial to study the efficacy and safety of a new drug P276-00 in the treatment of Mantle Cell Lymphoma
Efficacy Study of XL184 in Adults With Medullary Thyroid Cancer.
A clinical trial to study the safety and efficacy of Non-pegylated Liposomal Doxorubicin (Nudoxa) as compared to doxorubicin in A phase 3 clinical trial to study the long term safety and efficacy of darbepoetin alfa drug in drug induced anemia patients. A clinical trial to study the effect of HKI-272 in subjects with Advanced breast cancer
20-10-2009 14-10-2009 Onco
6/11/2009 24-11-2009 Onco
23-04-2010 21-04-2010 Onco
11/19/2009 11/18/2009 Onco
3/19/2010 3/16/2010 Onco
2/17/2010 1/7/2010 Onco
12/15/2009 12/15/2009 Onco
12/23/2009 1/1/2007 Onco
2/22/2010 4/30/2010 Onco
3/9/2010 3/5/2010 Onco
Phase 1b/2 clinical trial in patients with cancer to Evaluate the Safety and Efficacy of First-line Treatment With Epirubicin, Cisplatin, and A Phase II study in patients with Extensive-Stage Small Cell Lung Cancer.
A 24-week with possible extension, prospective, ulticentre, randomized, double blind, placebo-controlled, 2-parallel group with a A clinical trial to study the effect of NRC-AN-019 in patients with various cancers.
A Study of AVE8062 in Advanced-Stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies A clinical trial to study the prediction of result of chemotherapy in Acute myeloid leukemia by evaluating in vitro DNA damage. A clinical trial to study the efficacy of probiotic VSL#3 on chemotherapy-induced diarrhoea in cancer patients recieving A Phase 2 clincial trial to evaluate the Safety and Efficacy of drug FOLFIRI in Combination With drugs AMG 479 or AMG 655 Versus A phase 1 study to evaluate the bioequivalence of two formulation of capecitabine Tablets 500 mg tablets in patients of Breast Cancer or A study to assess the benefit of using growth factors in addition to antibiotics in children with febrile neutropenia
4/13/2010 4/9/2010 Onco
3/31/2010 6/15/2010 Onco
5/26/2010 5/19/2010 Onco
5/17/2010 5/13/2010 Onco
6/29/2010 1/1/2007 Onco
7/12/2010 7/2/2010 Onco
Imatinib pharmacokinetics and its correlation with response and safety in Indian children and adults with chronic phase chronic myeloid leukemia. Phase 3 clinical Study to Compare the Efficacy and Safety of drug product Panitumumab and Cetuximab in Subjects with Previously A clinical trial study of Sunitinib in biliary tract carcinoma after failure of first line treatment
Phase III, Multi-centre, Double Blind, Randomized Placebo Controlled Trial of Aspirin for Duke C and High Risk Dukes B Colorectal Cancers A Clinical trial of Infusion of Nanosomal Docetaxel Lipid Suspension (Intas Pharmaceuticals Ltd.) And Taxotere® in Breast Cancer A phase 2, open-label test-retest study to assess the reproducibility of quantitative measurements of 18F uptake by solid tumours using PET
Phase Site 1
100 Phase 2 6
68 Phase 2 4
Phase 3 1
900 Phase 3 1
25 Phase 2 1
20 Phase 2 1
60 Phase 2 1
46 1
300 1
Scientific Title of StudyWHO*
T. sample size
Esti trial duration
total Sites noA Phase IIb RCT of
Neoadjuvant chemotherapy comparing Paclitaxel, ifosfamide and Cisplatin with Paclitaxel,
2 Years Kashyap Nursing Home
Phase II Safety and Efficacy Study of the Monoclonal Antibody CT-011 in Patients with Diffuse Large B-Cell
915 Days Gujarat Cancer and Research Institute
Phase III Randomized Trial of Maintenance Pegylated Liposomal Doxorubicin (PLD) / Carboplatin versus
Months St. John's Medical College & Hospital
A multinational, Randomized, Double-Blind Study Comparing Aflibercept Versus Placebo in Patients
Orchid Nursing Home
Phase II study of Concurrent Chemoirradiation with weekly Paclitaxel and Cisplatin in the treatment
9 Months Department of Radiation Oncology Unit I,CHRISTIAN
MEDICAL COLLEGE ?Study on the efficacy of
Praneem Cream, Praneem Polyherbal tablets on HPV infection of the Cervix-uteri: A
3 Years Cancer Clinic, Department of
Obstetrics & Gynae
Phase II study of 3-Dimensional conformal Radiotherapy (3D-CRT) vs. Intensity Modulated Radiotherapy (IMRT) for
Years Dept. of Radiation Oncology
Head Shaving in Neurosurgery ? Implications on Surgical Site Infection and Cosmesis ? a feasibility
Not Applicable
Years Department of surgical oncology, ACTREC & TMC
A randomized double blind study of efficacy of Lactobacillus CD2 lozenges in preventing radiation and
Phase 2/Phase 3
Years Institute Rotary Cancer Hospital, All
India Institute of Medical Sciences, New Delhi-110029
49 Phase 2 6
54 Phase 2 7
Phase 1 5
3200 Phase 3 2
Phase 2 13
Phase 4 3
260 Phase 2 5
180 8 Mediciti Hospital,
172 Phase 3 1
6 V. N. Cancer Centre
A Phase II Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients
24 Months Orchid Nursing Home, Kolkata
An open label, multicenter Phase II study to evaluate efficacy and safety of P276-00 in Indian subjects with
Years Central India Cancer Research
Institute,11,Shankar Nagar, West High
Court Road,Nagpur - An Open Label, Multicenter Phase I Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In
Years Bhagwan Mahaveer Cancer Hospital,
JLN Marg, Jaipur 302017
A Multinational Randomized Double Blind, Placebo-controlled study to evaluate the efficacy and safety of
2 Years Jaslok Hospital and Research Centre
A phase II study to determine the safety, efficacy, and pharmacokinetics of multiple intravenous
Years Tata Memorial Hospital
An Open, Prospective, Non-comparative, Multicenter Study to Estimate the recovery after a single infusion of
Christian Medical College
An Asia Pacific non-randomized, open-label phase II study evaluating the safety and efficacy of FOLFIRI plus cetuximab
4 Years Rajiv Gandhi Cancer Institute & Research
Centre
A Multicenter, Open-Label, Randomized, Phase II/III Study to Evaluate the Safety and Efficacy of
Phase 2/Phase 3
3 Years
A randomized open labeled parallel group phase III study of low-dose versus standard-dose granulocyte colony
2 Years
An Open Label, Multicenter Phase I/II Study Of Selective Cyclin Dependent Kinase Inhibitor P276-00 In
Phase 1/Phase 2
Months
204 3
100 5
Phase 1 8
40 Phase 1 2
450 Phase 3 9
100 Phase 3 5
24 Phase 1 3
100 Phase 2 4
25 Phase 1 6
93 4
A Phase 1b/2 Trial of AMG 479 or AMG 102 in Combination With Platinum-Based Chemotherapy as First-
Phase 1/Phase 2
Kidwai Memorial Institute of Oncology
Neo-Adjuvant Docetaxel plus Platinum for Locally Advanced Breast Cancer (LABC): A single arm Observational Study.
Not Applicable
1 Years Birla Cancer Center, SMS Medical College
Hospital
Phase 1b Single Arm, Open Label, Multi-Center Study of Fluphenazine HCl Monotherapy in Relapsed or Relapsed-
Years Tata Memorial Hospital
An open label, Phase I dose escalation clinical trial of NRC-AN-019 in patients with all phases of Chronic Myeloid
12 Months Department of Medical Oncology
A multicenter, multinational phase 3 randomized study to evaluate the safety and efficacy of treating
2 Years Site No. 0791, Bangalore Institute
of Oncology
Efficacy and safety of TULY (rasburicase) in prevention and treatment of malignancy-associated hyperuricemia - An open-
6 Months 2. MNJ Institute of Oncology and
Regional Cancer Center
A Multicentre Phase I Study Of Cremophor FreePaclitaxel Nanoparticle In Advanced Breast Cancer.
1 Years Kidwai Memorial Institute of Oncology
A Phase 2, Multi-Center, Open-Label, Randomized Study of Mapatumumab (TRM-1 [HGS1012], a Fully Human Monoclonal
4.5 Years Rajiv Gandhi Cancer Institute & Research
Centre
Phase 1 safety, efficacy, and pharmacokinetic study of Paclitaxel nano-dispersion injection in subjects with metastatic
12 Months Shatabdi Superspeciality
Hospital, Nashik
A Phase I/II Study of HKI-272 in Combination With Paclitaxel in Subjects With Advanced Solid Tumors and Breast
Phase 1/Phase 2
22 Months Maharashtra Medical
Foundation's (MMF) Joshi Hospital
120 Phase 3 13
8000 Phase 3 7
Phase 2 7
Phase 2 11
800 Phase 3 9
450 Phase 3 6
Phase 1 4
3000 Phase 3 7
70 Phase 1 2
20 1
A Prospective, Comparative, Randomized Multicenteric Phase III study to compare the
11 Months NRN Orthopaedic Clinic
EGF106708 : A Randomised, Multi-Centre, Open-Label, Phase III Study of Adjuvant Lapatinib,
All India Institute of Medical Sciences
A Phase 2, Randomized, Open-Label Study of Bosutinib Administered in Combination With Exemestane Versus
Months Tata Memorial Centre
A Multicenter, Open-Label, Randomized, Phase 2 Study to Evaluate the Efficacy and Safety of NKTR-102 (PEG-
Months Hemato-Oncology Clinic Ahmedabad
Pvt.Ltd.
A Phase 3b, Randomized, Open-Label Study of bevacizumab (AVASTIN®) + temsirolimus
48 Months SEAROC Cancer Centre
EGF106903 : Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study A
Ruby Hall Clinic-Cancer Centre
An open label, balanced, randomized, two period, two treatment, two sequence, and two way crossover study to
M S Patel Cancer Centre
EGF105485: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study of Adjuvant Lapatinib
Ruby Hall Clinic-Cancer Centre
VEG105424 : An Open-Label, Pharmacokinetic Study of the Safety and Tolerability of Pazopanib in Combination With
NIMS,Medical Oncology Dept.
Optimizing the physical and biological parameters in craniospinal irradiation (CSI) for average risk
Phase 1/Phase 2
36 Months Advanced Centre for Treatment Research
and Education
20 1
1200 Phase 3 13
30 Phase 1 16
20 2
150 Phase 3 14
Phase 2 6
Phase 3 9
6 Jaslok Hospital
3000 Phase 3 20
122 Phase 2 4
Feasibility Study Evaluating Bladder Preservation By Helical Tomotherapy Based IMRT In Muscle Invasive
Not Applicable
2 Years Tata Memorial Centre
A Phase 3, Randomized, Open-Label, Two-Arm Study of Neratinib (HKI-272) Plus Paclitaxel Versus Trastuzumab Plus
Months Tata Memorial Hospital
A multicentre, randomized, open label, two-period, two-treatment, two-way crossover, bioequivalence
5 Months Curie Manvata Cancer centre, Opp.
Mahamarg Bus stand, Mumbai Naka, Nashik, A Phase I/II multicenter
study of IY5511HCI in Philadelphia chromosome positive chronic myeloid leukemia patients without
Phase 1/Phase 2
18 Months Dept. Of Medical Oncology, Prince Aly
Khan Hospital
A randomized, multi-center, open label study to evaluate the efficacy and safety of Peg G-CSF as compared to Grafeel® in
21 Months Amrita institute of medical sciences
Single-Arm, Open-Label, Multicenter Phase II Study to Evaluate the Efficacy and Safety of P276-00 in Patients With
Years Tata Memorial Hospital, Dr. E.
Borges Marg, Parel, Mumbai-400012
An International, Randomized, Double-Blinded, Phase 3 Efficacy Study of XL184 versus Placebo in Subjects with
Months All India Institute of Medical Sciences
A phase II/III Open label Multicentric Randomized trial to determine the safety and efficacy of Non-pegylated Liposomal
Part A:12, Phase 2/Phase 3
Two Years
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long-term Safety and Efficacy of Darbepoetin
10 Years IRL Research Centre,
Phase 2 Study of HKI-272 in Subjects with Advanced Breast Cancer
3 Years Nizam's Institute of Medical Sciences
136 6
154 Phase 2 11
200 Phase 3 19
72 Phase 1 2
300 Phase 3 4
30 1
242 1
150 Phase 2 5
110 10
200 Phase 3 1
A Multicenter, Double-Blind, 3-Arm, Phase 1b/2 Study in Subjects With Unresectable Locally Advanced or Metastatic
Phase 1/Phase 2
4 Years Tata Memorial Hospital
A Phase I Followed by a Randomized, Phase II Study of Carboplatin and Etoposide with or without Obatoclax Administered
Months G Kuppuswamy Naidu Memorial
Hospital
A 24-week with possible extension, prospective, ulticentre, randomized, double blind, placebo-controlled, 2-parallel
30 Months Choithram Hospital and Research Centre
A Phase-I Clinical Study to Evaluate the Safety, Pharmacokinetics and Anti-Tumor Activity of NRC-AN-019 in Patients
1 Years Krishna Institute of Medical Sciences
A multinational, randomized, double-blind placebo controlled study of AVE8062 (25 mg/m²) administered every 3
3 Years FR. Muller Hospital Department of
Radiation Oncology
In vitro DNA damage assessment as predictor of response to chemotherapy in acute myeloid leukemia.
Not Applicable
2 Years Department of Pharmacology and
Department of Medical Oncology, AIIMS, New Delhi
A phase II / III, randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic
Phase 2/Phase 3
2 Years All India Institute of Medical Sciences
A Phase 2, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of FOLFIRI in
4.5 Years Kidwai Memorial Institute of Oncology
A multicentre, randomized, open label, two-period, two-treatment, two-way crossover, bioequivalence
Not Applicable
06 Months Noble Hospital (Oncology
Department),153, Magar patta, City Road,Pune-411013
A randomized open labeled parallel group phase III study of antibiotics alone versus antibiotics plus
2 Years Tata Memorial Hospital
68 1
60 (India) Phase 3 9
59 Phase 2 1
2660 Phase 3 4
72 Phase 2 6
upto 45 Phase 2 2 Manipal Hospital,
A Randomized, Multicenter, Open-label, Phase 3 Study to Compare the Efficacy and Safety of Panitumumab
Not Applicable
2 Years Department of Medical Oncology
A Randomized, Multicenter, Open-label, Phase 3 Study to Compare the Efficacy and Safety of Panitumumab
4 Years Kidwai Memorial Institute of Oncology,
Aspirin for Duke C and High Risk Dukes B Colorectal Cancers. An International, Multi-centre, Double Blind,
18 Months Rajiv Gandhi Cancer Institute & Research
Centre
Aspirin for Duke C and High Risk Dukes B Colorectal Cancers. An International, Multi-centre, Double Blind,
8 Years Department of Medical Oncology, Kidwai Memorial
Institute of Oncology, Hosur
An Open Label, Randomized, Multiple-Dose, Parallel Study To Evaluate The Safety And Efficacy Of Intravenous
17 Months IndoAmerican Cancer
Hospital,Road No. 14, Banjara Hills,
HyderabadA phase 2, open-label test-retest study to assess the reproducibility of quantitative measurements of 18F
24 Months
Site 2 Site 3 Site 4 Site 5
INHS Ashwini Hospital
Dinanath Mangeshkar hospital
Mahavir Cancer Hospital
O P Jindal Institute
Jaslok Hospital and Research Centre,
Dept. of Oncology, 15, Dr. G.
Rajiv Gandhi Cancer Institute and
Research Centre, Department of
Deenanath Mangeshkar Hospital and
Research Centre, Department of
Shatabdi Hospital
S. L. Raheja Hospital
Ruby Hall Clinic
Kidwai Memorial Institute of
Oncology, Bangalore
Medical College, Kozhikode
Apollo Hospital, Bangalore
Yashoda Hospital, Hyderabad
Dept. Of Surgical Oncology, CSM
Medical University, King george Medical University, Lucknow
Division of Head & Neck
Oncology,Regional cancer
Centre,Medical
Bhagwan Mahaveer Cancer Hospital &
Research Centre,Dept. Of
Medical
Bharath Hospital & Institute of
Oncology,Outer Ring Road,438 - Hebbal,
Mysore - 570017Jehangir Hospital, 32, Sassoon Road,
Pune 411001
Ruby Hall Clinic, New Cancer Bldg.,
3rd Floor, 40, Sassoon Road, Pune
411 001.
SEAROC Cancer Centre, S. K. Soni
Hospital, Sec-5 Vidhyadhar Nagar, Sikar Road, Jaipur
Tata Memorial Centre, Department of Medical Oncology,
Dr. Ernest Borges Road, Parel ,
Sri Ganga Ram Hospital
Kidwai Memorial Institute of Oncology
SEAROC Cancer Center
Jehangir Clinical Development Centre
Pvt. Ltd.
St. Johns Medical College & Hospital
King Edward Memorial Hospital
Sir Ganga Ram Hospital
Tata memorial hospital
All India Institute of Medical sciences
All India Institute of Medical Sciences
Shirdi Sai Baba Cancer Hospital
Katsurba Medical College & Hospital
Manipal
Apollo Cancer Institute
Bhagwan Mahawir Cancer Hospital & Research Centre
Government Medical College
Christian Medical College
Curie Manavata Cancer Center
S. K. Soni Hospital
3. NIMS Hospital
KEM Hospital, pune
Birla Cancer Centre
Tata Memorial Centre
Kashyap Nursing Home
Sparsh Hospitals and Critical care (p) ltd
Bhagwan Mahaveer Cancer Hospital & Research Centre
Mahaveer Cancer Sansthan
Netaji Subhash Chandra Bose
Cancer Research Institute
Indira Gandhi Institute of Medical
Sciences
Max Super Specialty Hospital
Kidwai Memorial Institute of Oncology
Department of Hematology, All India Institute of Medical Sciences
Site No. 0789, Tata Memorial Hospital,
Site No. 0787, Regional Cancer
Centre
Site No. 0792, Mahaveer Cancer
Sansthan
Site No. 0793, Jawaharlal Nehru
Cancer Hospital and Research Center
1. Bangalore Institute of Oncology
4. Indo-American Cancer Institute and
Research Center
5. King George Hospital, Andhra Medical College
Nizam's Institute of Medical Sciences
SEAROC Cancer Center
All India Institute of Medical Sciences
Bangalore Institute of Oncology
Bharath Hospital & Institute of Oncology
Manavata Curie Research centre
Kailash Cancer Hospital, Goraj
Apollo Hospital, Ahmedabad
Jehangir Clinical Development Centre
Tata Memorial Centre
Sushrut Hospital Yash Hospital
Jeevandip Hospital
shreeji Orthopedic and ENT Hospital
95/B,Siddhatek Appartments,
Central India Cancer Research Institute
Apollo Hospital Educational and
Research
Tata Memorial Hospital
NIMS, Department of Medical Oncology
SEAROC Cancer Centre
Jawaharlal Nehru Cancer Hospital & Research Centre
Jehangir Clinical Development Centre
Private Limited
Kaushalya Medical Foundation Trust
Hospital
Chittaranjan National Cancer
Institue
Curie Manavata Cancer Centre
Kodlikeri Memorial Hospital
Rajalakshmi Multispeciality
Hospital
Apollo Speciality Hospital
Hemato-Oncology Clinic Ahmedabad
Pvt. Ltd
Jawaharlal Nehru Cancer Hospital & Research Centre
Jehangir Clinical Development Centre
Private Limited
Tata Memorial Hospital
Nizam's Institute of Medical Sciences
Apollo Hospital's Educational &
Research Foundation (Spectra Clinical
Research)
vCentral India Cancer Research
Institute
Mahavir Cancer Sansthan
Meeneakshi Mission Hospital and Rearch
Centre
Tata Memorial Hospital
All India Institute of Medical Sciences
Nizam's Institute of Medical Sciences
SEAROC Cancer Centre
Tata Memorial Hospital
Ruby Hall Clinic
Jehangir Hospital
Jawaharlal Nehru Cancer Hospital & Research Centre
Birla Cancer Centre, SMS Medical College
and Hospital
SEAROC Cancer Centre, S.K. Soni
Hospital
Central India Cancer Research Institute
Deenanath Mangeshkar
Hospital, Erandwane, Pune-
411004 Maharashtra
Ruby Hall Clinic 40 , sasoon Road, Pune-
411001
Meeneakshi Mission Hospital and Rearch Centre, Lake Area,
Melur Road, Madurai - 625107
PSG Institute of Medical Sciences &
Research,Off Avanashi Road,
Peelamedu,CoimbatoDepartment of
medical Oncology
Lakeshore Hospital & Research Centre
Ltd
Apollo Specialty Hospital
Indo American Cancer Institute and
Research Centre
Nizam's Institute of Medical Sciences
Cancer Care Clinic and Hospital, 5th
floor, Vasant Sheela Tower, Lokmat
Square, Nagpur-
Institute Rotary Cancer Hospital, All
India Institute of Medical Sciences, New Delhi 110029
Malabar Institute of Medical Sciences, Govindapuram,
Calicut, Kerala- 16
St. Johns Medical College & Hospital,
Sarjapur Road, Bangalore 34
Deenanath Mangeshkar
Hospital & Research Center
Shatabdi Superspeciality
Hospital
Kidwai Memorial Institute Of Oncology
The Gujarat Cancer & Research Institute
Vedanta Institute of Medical Sciences
Dharamshila Hospital and
research centre
B.L. Kapur Memorial Hospital,
Kidwai Memorial Institute of Oncology
Jewaharlal Nehru Cancer Hospital and
Research Centre
Govt Medical College and Hospital
MNJ Institute of Oncology
Tata Memorial Hospital
Deenanath Mangeshkar Hospital and
Research Centre
Kothari Skin Centre
Apollo Hospitals
Shatabdi Hospital
Kidwai Memorial Institute of Oncology
Jawaharlal Nehru Cancer Hospital
Indo-American Cancer Institute & Research Centre
Curie Manavata Cancer Centre
Acharaya Harihar Regional Cancer
Centre
Jawaharlal Nehru Cancer Hospital & Research Centre
Curie Manavata Cancer Centre
Orchid Nursing Home
St. John's Medical College and Hospital
Deccan College of Medical Sciences
LTM medical college & LTM general
hospital
Nizams Institute of Medical Sciences
India Apollo Hospital, Education
& Research Foundation (Spectria Clinical Research),
Gokula Metropolis Clinical Research
Cente
Tata Memorial Hospital
MNJ Institute of Oncology
Jawaharlal Nehru Cancer Hospital and
Research Centre
Central India Cancer Research Centre, 11
Shankarnagar, Nagpur-440011,
India
Manvata Curie Cancer centre, Opp.
Mahamarg Bus stand, Mumbai Naka, Nashik,
Shatabdi Hospital, Suyojit City
Center,Mumbai Naka, Nashik,
Maharashtra-422005
Dr.Rai Memorial Medical Centre, No: 562 - Century Plaza, Teynampet,Chennai
- 600018
Shatabdi Hospital, Curie Manavata Cancer Centre,
MNJ Institute of oncology and
Research Cancer Centre,
Indo-American Cancer Institute & Research Centre
Regional Cancer Centre
Tata Memorial Hospital
Dr. B.R.A Institute Rotary Cancer
Hospital, AIIMS, Ansari Nagar
Shalby Hospital, Opp. Karnavti Club,
S G High way, Ahmedabad
Moolchand Medcity, Main Ring Road,
Lajpatnagar III, New Delhi
CHL Apollo Hospital, Nr. L.I.G
Triangle, A.B. Road, Indore. M.P.
"Additional Professor, Breast
Cancer Clinic,Regional
Cancer Bangalore Institute
of Oncology,
Site 6 Site 7 Site 8 Site 9
Sanchetee Hosp & Cancer Inst
GKNM Hospital, GKNM Hospital,
Kidwai Hospital
Nizam's Institute of Medical Science,
Hyderabad
Jaslok Hospital,15,Dr.G.Deshmukh Marg,Peddar
Road,Mumbai-400026
Kashyap Nursing Home, Imperial
mahal, Dadar TT. Mumbai - 14
Curie Manavata Cancer Centre,
Dr Kamakshi Memorial Hospital
Tata Memorial Hospital
Christian Medical College
Meenakshi Mission Hospital & Research
Centre
Amrita Institute of Medical Sciences
M.S. Ramaiah Medical College and Teaching Hospital
Malabar Institute of Medical Sciences
Site No. 0784, Shatabdi Super
Specialty Hospital
Site No. 0786, SEAROC Cancer Center, S. K. Soni
hospital
Site No. 0785, Cancer Clinic, Shreevardhan
complex
Denananath Mangeshkar
Hospital, Pune
Aakar HospitalGandhi Orthopaedic Hospital
Jivani orthopedic, arthroscopy hospital
Princess Durru Shehwar Hospital
Netaji Subhash Chandra Bose
Cancer Research Institute
Regional Cancer Center
Curie Manavata Cancer Centre
Dharamshila Hospital and
Research Centre
M.S. Ramaiah Memorial Hospitial
B.P. Poddar Hospital and Medical
Research Ltd.
Mehendi Nawaz Jung Institute of
Oncology and Regional Cancer
Centre
Amrita Institute of Medical Sciences
Bangalore Institute of Oncology
Lakeshore Hospital and Research Centre
Ltd.,
Regional Cancer Centre
Tata Memorial Centre
Kidwai Memorial Institute of Oncology
Apollo Speciality Hospital
Jehangir Hospital and Medical Centre
Jaslok Hospital Joshi Hospital
Ruby Hall Clinic
Curie Manavata Cancer Centre
Meenakshi Mission Hospital and
Research Centre
B P Poddar and Medical Research
Ltd.
Shatabdi Super Speciality Hospital
Department of Radiotherapy,
Christian Medical College,IDA Scudder
Road,Vellore - 632
Netaji Subhash Chandra Bose
Cancer Research Institute, 16A, Park Lane, Kolkata-16
Dept. of Medical Oncology, M S Patel
Cancer Centre, Shree Krishna
Hospital, Gokal
Mahavir Cancer Sansthan, Phulwari
Sharif, Patna
Asian Institute of Oncology, S.L.
Raheja Hospital
Jawaharlal Nehru Cancer Hospital & Research Centre
Meenakshi mission hospital and research
centre
Netaji Subhash Chandra Bose
Cancer Research Institute
The Indo-American Cancer Institute & Research Centre
Central India Cancer Research Institute
SEAROC Cancer Centre
Sheth Nandlal Dhoot Hospital
Kaushalya Medical Foundation Trust
Hospital
Pravara Institute of Medical Sciences
Indo-American Cancer Institute & Research Centre
Noble Hospital
178-Dh Sector Cancer Clinic
Amrita Institute of Medical Sciences & Research Centre,
Orchid Nursing Home
Tata Memorial Hospital
Dr. Kamakshi Memorial Hospital
Government Cancer Hospital
Smt. S. C. L. Hospital
Meeneakshi Mission Hospital,Melur
Road, Madurai - 625107
Cancer hospital & research institute,
Regional Centre for Cancer Research & Treatment, Cancer
Dept. of Medical Oncology, M S Patel
Cancer Centre, Shree Krishna
Hospital, Gokal
Mahavir Cancer Sansthan, Phulwari
Sharif, Patna
S. K. Soni HospitalRural Medical College, PIMS
Department of Medical Oncology,
Deenanath Mangeshkar
Hospital
"Lions Cancer Detection Center,
New Civil Hospital, Majura Gate, Surat,
Gujarat.
Site 10
Orchid Nursing Home
IndoAmerican Cancer Institute & Research Center
Mahavir Cancer Sansthan
Indira Gandhi Institute of Medical Sciences
Dia Care Research Orthopaedic ClinicMadhu Orthopaedic Fracture & Accident Hospital,
Karne Hospitals Private Limited
Shatabti Superspeciality Hospital
Kaushalya Medical Foundation Trust Hospital
S. K. Soni Hospital,
Dayanand Medical College & Hospital
Institute Rotary Cancer Hospital, All India Institute of Medical Sciences
Deenanath Mangeshkar Hospital and Research Centre
Christian Medical College
M.D. Oswal Cancer Treatment & Research Foundation, G.T Road, Sherpur by
Jeevandeep Hospital, Station Road , Surat
Kaushalya Medical Foundation Trust Hospital.Thane (w)-400601
Hemato-Oncology Clinic, Vedanta Institute of Medical Science
Artemis Medicare Services Pvt Ltd
Dayanand Medical College & Hospital
Orchid Nursing Home
Seth Nandlal Dhoot Hospital
A.H.Regional Cancer Center
LRS Instiute of TB & Respiratory diseases
B.J.Medical college New civil hospital
Hemato Oncology Clinic
Galaxy Cancer Institute
Sheth V. S. Hospital &. N. H. L- Municipal Medical College
Gandhi Medical College
Jeevandeep Hospital, 302, 3rd floor, Ayush Doctor House, Station Road, Surat
Jehangir Hospital
V.S. Hospitals Pvt. Ltd.
Chhatrapati Shauji Maharaj Medical University
SMS Medical College Hospital
Curi Manavata Cancer Centre
University College of Medical Sciences & GTB Hospital
Shri B.M.Patil Medical College
Amrita Institute of Medical Sciences and Research Centre
Govt. Medical College
Lakeshore Hospital & Research Centre Ltd
Shri Sidhivinayak Ganapati Cancer Hospital
Tata Memorial Centre
Dayanand Medical College & Hospital
Clinical trial registry database India/WHO
S. no Trial CTRI No.and Date
1 trial 1
2 trial 2
3 Trial 3
4 Trial 4
5 Trail 5
6 Trial 6
7 Trial 7
8 Trial 8
9 Trial 9
UTRN.WHO
TEMP UTRN 123314078-31122008411821
CTRI/2008/091/000309, 16-01-2009
TEMP UTRN 093845302-09012009425431
CTRI/2009/091/000013, 01-12-2009
TEMP UTRN 052227973-28012009460856
CTRI/2009/091/000043, 13-10-2009
TEMP UTRN 123500298-11032009513970
CTRI/2009/091/000093, 01-07-2009
TEMP UTRN 110650739-2311200914682002
CTRI/2009/091/000976, 30-12-2009
TEMP UTRN 043939650-2611200914821953
CTRI/2009/091/000988, 08-12-2009
TEMP UTRN 112812871-29052009766602
CTRI/2009/091/000320, 17-06-2009
TEMP UTRN 104431905-070520096911045
CTRI/2009/091/000249, 15-09-2009
TEMP UTRN 054352547-180720091034856
CTRI/2009/091/000571, 13-01-2010
10 Trial 10
11 Trial 11
12 Trial 12
13 Trial 13
14 Trial 14
15 Trial 15
16 Trial 16
17 Trial 17
18 Trial 18
19 Trial 19
20 Trial 20
TEMP UTRN 121549629-1008200910981953
CTRI/2009/091/000633, 17-09-2009
TEMP UTRN 094148451-110820091102602
CTRI/2009/091/000636, 24-09-2009
TEMP UTRN 050650045-2808200911561804
CTRI/2009/091/000687, 17-11-2009
TEMP UTRN 063841923-10112009142427
CTRI/2009/091/000935, 24-02-2010
TEMP UTRN 114438089-3012200915861804
CTRI/2009/091/001085, 17-02-2010
TEMP UTRN 100748644-1901201016731444
CTRI/2010/091/000071, 16-02-2010
TEMP UTRN 064836834-0904201019671078
CTRI/2010/091/000348, 18-05-2010
TEMP UTRN 075744238-1604201020103408
CTRI/2010/091/000389, 04-06-2010
TEMP UTRN 115422816-1201201016461032
CTRI/2010/091/000046, 05-02-2010
TEMP UTRN 121831302-0503201018261444
CTRI/2010/091/000212, 22-06-2010
TEMP UTRN 043759194-2203201019002629
CTRI/2010/091/000282, 11-05-2010
21 Trial 21
22 Trial 22
23 Trial 23
24 Trial 24
25 Trial 25
26 Trial 26
27 Trial 27
28 Trial 28
29 Trial 29
30 Trial 30
31 Trial 31
TEMP UTRN 112127770-1705201021413503
CTRI/2010/091/000516, 08-07-2010
TEMP UTRN 123138764-24062009898599
CTRI/2009/091/000440, 27-07-2009
TEMP UTRN 112509752-10102008300599
CTRI/2008/091/000203, 01-01-2009
TEMP UTRN 122452186-10102008301599
CTRI/2008/091/000204, 11-02-2009
TEMP UTRN 110920818-21122008400346
CTRI/2008/091/000298, 27-05-2009
TEMP UTRN 052227973-28012009460856
CTRI/2009/091/000043, 13-10-2009
TEMP UTRN 123500298-11032009513970
CTRI/2009/091/000093, 01-07-2009
TEMP UTRN 112812871-29052009766602
CTRI/2009/091/000320, 17-06-2009
TEMP UTRN 100335508-03062009782602
CTRI/2009/091/000335, 17-06-2009
TEMP UTRN 012607951-070720099881728
CTRI/2009/091/000525, 11-08-2009
TEMP UTRN 043421444-25062009919602
CTRI/2009/091/000459, 06-08-2009
32 Trial 32
33 Trial 33
34 Trial 34
35 Trial 35
36 Trial 36
37 Trial 37
38 Trial 38
39 Trial 39
40 Trial 40
41 Trial 41
42 Trial 42
CTRI/2009/091/000681, 17-09-2009
CTRI/2009/091/000681, 17-09-2009
TEMP UTRN 033202200-0309200911821247
CTRI/2009/091/000713, 11-09-2009
TEMP UTRN 051827877-3009200912861009
CTRI/2009/091/000808, 11-12-2009
TEMP UTRN 063841923-10112009142427
CTRI/2009/091/000935, 24-02-2010
TEMP UTRN 041901423-020220101719602
CTRI/2010/091/000110, 15-04-2010
TEMP UTRN 041732350-0802201017432868
CTRI/2010/091/000132, 09-03-2010
TEMP UTRN 073931347-2704201020623444
CTRI/2010/091/000438, 19-05-2010
TEMP UTRN 031858125-30122008408741
CTRI/2008/091/000306, 05-02-2009
TEMP UTRN 040657729-200320095291096
CTRI/2009/091/000109, 10-06-2009
TEMP UTRN 023531053-1105201021203247
CTRI/2010/091/000495, 19-05-2010
TEMP UTRN 123314078-31122008411821
CTRI/2008/091/000309, 16-01-2009
43 Trial 43
44 Trial 44
45 Trial 45
46 Trial 46
47 Trial 47
48 Trial 48
49 Trial 49
50 Trial 50
51
52
53
TEMP UTRN 123314078-31122008411821
CTRI/2008/091/000309, 16-01-2009
TEMP UTRN 013302077-21102008310637
CTRI/2008/091/000213, 02-07-2009
TEMP UTRN 100727349-2807200910581889
CTRI/2009/091/000594, 11-08-2009
TEMP UTRN 020754308-080620097971475
CTRI/2009/091/000347, 08-07-2009
TEMP UTRN 104145110-200620098641475
CTRI/2009/091/000407, 06-07-2009
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
Clinical trial registry database India/WHO
Status of TrialWHO Last Verified on
Not yet recruiting
1/16/2009 1/16/2009 ACS
12/1/2009 7/7/2010 ACS
Open to recruitment
10/13/2009 6/25/2010 ACS
Terminated
7/1/2009 10/21/2009 ASC
Completed
12/30/2009 6/25/2010 ACS
Open to recruitment
12/8/2009 4/29/2010 ACS
Open to recruitment
6/17/2009 6/8/2010 ACS
Open to recruitment
9/15/2009 10/1/2009 ACS
Open to recruitment
1/13/2010 4/12/2010 ACS
Last Updated on Speciality-Subspeciality
Closed to recruitment follow up continuing & closed to recruitment
follow up complete fully
Open to recruitment
9/17/2009 11/20/2009 ACS
Open to recruitment
9/24/2009 11/12/2009 ACS
Open to recruitment
10/30/2009 17-11-1009 ACS
Open to recruitment
2/24/2010 2/16/2010 ACS
Open to recruitment
2/17/2010 02--4-2010 ACS
Open to recruitment
2/16/2010 5/11/2010 ACS
Open to recruitment
2/16/2010 7/6/2010 ACS
Open to recruitment
6/4/2010 6/1/2010 ACS
Open to recruitment
2/5/2010 7/12/2010 ACS
Open to recruitment
6/22/2010 6/25/2010 ACS
Open to recruitment
5/11/2010 5/11/2010 ACS
Open to recruitment
7/8/2010 7/8/2010 ACS
27-07-2009 23-07-2009 HF
Open to recruitment
1/1/2009 21-04-2010 HF
Open to recruitment 11/2/2009 11/2/2009
HF
Completed 5/27/2009 4/8/2010
HF
Open to recruitment 10/13/2009 6/25/2010
HF
Terminated 7/1/2009 10/21/2009
HF
Open to recruitment 6/17/2009 6/8/2010
HF
Open to recruitment 6/17/2009 5/28/2010
HF
Open to recruitment 8/11/2009 7/27/2009
HF
Open to recruitment 8/6/2009 1/15/2010
HF
Closed to recruitment of participants
Open to recruitment 9/17/2009 5/14/2010
HF
Open to recruitment 9/11/2009 9/10/2009
HF
12/11/2009 2/25/2010
HF
Open to recruitment 2/24/2010 2/16/2010
HF
Open to recruitment 4/15/2010 6/22/2010
HF
Open to recruitment 3/9/2010 6/18/2010
HF
Open to recruitment 5/19/2010 5/7/2010
HF
Completed 2/5/2009 3/30/2009
IHD
Completed 6/10/2009 6/25/2010
IHD
Open to recruitment 5/19/2010 5/17/2010
IHD
Not yet recruiting 1/16/2009 1/16/2009 Unstable Angina
Temporary halt or suspended
Not yet recruiting 1/16/2009 1/16/2009
Angina
7/2/2009 7/8/2009
8/11/2009 4/14/2010
7/8/2009 5/10/2010
7/6/2009 5/10/2010
Closed to recruitment of participants Coronary Artery
Disease
Closed to recruitment of participants Coronary Artery
Disease
Closed to recruitment of participants Coronary Artery
Disease
Closed to recruitment of participants
Clinical trial registry database India/WHO
Public Title StudyWHO* Scientific Title of StudyWHO*
40
4000
300
NA
200
1264
220
T. sample size
A study to assess the safety and efficacy of Fondaparinux in unstable angina and non-ST elevation myocardial infarction compared to historical controls
A prospective, single arm, open trial to assess the safety and efficacy of Fondaparinux in patients with unstable angina and non-ST elevation myocardial infarction compared to
AR1108888 : FondaparinUx Trial with UFH during Revascularization in Acute Coronary Syndromes (FUTURA/OASIS 8)
FondaparinUx Trial with UFH during Revascularization in AR1108888: Acute Coronary Syndromes (FUTURA) A prospective study evaluating the safety of two
A Phase II clinical trial to study the effects of TRC4186, an investigational new drug in patients with stable heart failure associated with type 2 diabetes
Safety and Efficacy of TRC4186 in the treatment of stable heart failure associated with HbA1 ≥ 6.5% or type 2 Diabetes receiving oral hypoglycaemic therapy (with or
A Clinical Trial to Assess The Effects of a Drug, BG9928, given intravenously, in Subjects With Acute Decompensated Heart Failure (ADHF) and Reduced A clinical trial to study the effects of drug, Prasugrel in patients with acute coronary syndrome.
"A DOUBLE BLIND, RANDOMIZED, MULTICENTRIC, PHASE-III TRIAL TO COMPARE THE EFFICACY, TOLERABILITY, AND SAFETY OF TABLET
Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects with Acute Coronary Syndromes
A Randomized, Double-Blind, Placebo Controlled Multi- Center and Parallel Group Study of the Safety, Tolerability and Efficacy of YM150 in combination with Standard
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-Mortality in Patients With Chronic Heart Failure (ATMOSPHERE)
A Multicenter, Randomized, Double-Blind, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril
A Clinical Trial to Evaluate the Safety and Efficacy of Apixaban In Subjects with a Recent Acute Coronary Syndrome
A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects with a Recent Acute Coronary Syndrome
A clinical trial to study the effects of two drugs, prasugrel and clopidogrel in patients with acute coronary syndrome who are to undergo percutaneous
A prospective, randomised, double-blind, double dummy, comparative, parallel assignment, multicentric clinical trial to compare the safety and efficacy of Prasugrel vs.
50
240
500
30
5400
11500
140
A study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects with atrial fibrillation.
A Phase 2, Double-Blind, Double-Dummy, Randomized, Parallel Group Dose Finding Study To Investigate the Safety and Tolerability of YM150 in Subjects with Non-Valvular Atrial
Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients
Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration for the Treatment of Hyperglycemia in Metformin Monotherapy Treated
A study of the clinical experience with atorvastatin 80 mg in patients with acute coronary syndromes (heart attack )
Post-marketing study of clinical experience of Lipicure 80® (atorvastatin 80 mg) in patients with acute coronary syndromes Acronym: Cure - ACS
A clinical trial to study the effect of standard treatment of heart failure on plasma levels of Apelin in patients with heart failure.
Effect of Therapy on Plasma Apelin Levels in Patients of Heart Failure.
CLINICAL TRIAL FOR EVALUATION OF EFFICACY AND SAFETY OF PRASUGREL IN COMPARISON WITH
AN OPEN LABEL, RANDOMIZED, PARALLEL GROUP, PROSPECTIVE, MULTICENTRE CLINICAL TRIAL FOR EVALUATION OF EFFICACY
A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine.
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With
A Study of Acute Coronary Syndrome Patients
A Comparison of Platelet Inhibition Following a Prasugrel 60 mg or Prasugrel 30 mg Loading Dose With or Without Pretreatment With a Clopidogrel Loading Dose in Acute
A STUDY TO EVALUATE THE EFFECT OF EDIBLE OIL IN PATIENTS OF TYPE II DIABETES MELLITUS & HYPERTENSION.
A STUDY TO EVALUATE THE EFFECT OF EDIBLE OIL (RBS8020) IN PATIENTS OF TYPE II DIABETES MELLITUS & HYPERTENSION
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome (EXAMINE)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment with Alogliptin in Addition to Standard of Care in
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial (SOLID-TIMI 52)
A Clinical Outcomes Study of Darapladib versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular
A Phase IIa, Randomized, Single-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of 28-day Repeat
GSK PHI112844: A Phase IIa, Randomized, Single-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of 28-
600
2300
800-1000
2000
28
300
124
A clinical trial to study reduction of cardiovascular mortality and morbidity in Type 2 diabetes mellitus patients with a recent Acutecoronarysyndrome event
Cardiovascular outcomes study to evaluate the potential of aleglitazar to reduce cardiovascular risk in patients with a recent acute coronary syndrome (ACS) event and type 2
DOT-HF Trial - International trial to determine the diagnostic outcome in Heart Failure
DOT.HF Diagnostic Outcome Trial in Heart Failure
South Asian Systolic Heart Failure Registry (SASHFR) : Registry to understand benefits of implantable device therapy known as cardiac
SASHFR (South Asian Systolic Heart Failure Registry) : A multi-center, nonrandomized, prospective study to collect data pertaining to the demographic and cardiovascular
PANARM HF : A clinical registry to understand the disease profiles of patients who suffer from cardiac arrhythmias and/or heart failure and to understand the diagnosis
PANARM HF -A prospective, multi-center, non-interventional to collect (at the referring physician stage), data pertaining to the demographic, cardiovascular and disease etiology
Cardiac rehabilitation and quality of life in congestive heart failure
The effects of exercise based cardiac rehabilitation on quality of life in congestive heart failure
A Phase II clinical trial to study the effects of TRC4186, an investigational new drug in patients with stable heart failure associated with type 2 diabetes mellitus
Safety and Efficacy of TRC4186 in the treatment of stable heart failure associated with HbA1 ≥ 6.5% or type 2 Diabetes receiving oral hypoglycaemic therapy (with or
A Clinical Trial to Assess The Effects of a Drug, BG9928, given intravenously, in Subjects With Acute Decompensated Heart Failure (ADHF) and Reduced
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess The Effects of Intravenous BG9928 on Body Weight in Subjects with Acute
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-Mortality in Patients With Chronic Heart Failure (ATMOSPHERE)
A Multicenter, Randomized, Double-Blind, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril
Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Effect of 52 Weeks Treatment With Vildagliptin on Left Ventricular
A clinical trial to study the effects of propranolol (a beta blocking drug) in children with ventricular septal defect and heart failure
Ventricular Septal Defect - Propranolol for Heart Failure (VSD-PHF Study)
Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart
A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the 6 Months Efficacy and Safety of Aliskiren Therapy on Top of
290
40
200
50
7980
11330
102
10
40
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-Ventricular Ejection Fraction
A Thirty Six-Week, Randomized, Double-Blind, Multi-Center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to
A clinical study to evaluate performance of a non-invasive study device to monitor patients fluid status in congestive heart failure.
Adherent Monitoring of Congestive Heart Failure during Therapy for Excess Fluid (ACUTE) Study
A comparative evaluation of efficacy, safety & tolerability of Carvedilol Phosphate Extended Release Capsules 80 mg (Test Drug), with Carvedilol Phosphate
A comparative, single blind, parallel group, non-crossover, multi-centric trial of Carvedilol Phosphate Extended Release Capsules 80 mg (Test Drug), with Carvedilol
A clinical trial to study the effect of standard treatment of heart failure on plasma levels of Apelin in patients with heart failure.
Effect of Therapy on Plasma Apelin Levels in Patients of Heart Failure.
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity
A clinical trial with ivabradine in patients with stable coronary artery disease
Effects of ivabradine in patients with stable coronary artery disease without clinical heart failure. A randomised double-blind placebo-controlled international multicentre
A clinical trial to study the efficacy and safety of metoprolol in heart failure with normal ejection fraction
Evaluation of efficacy and safety of metoprolol in patients having heart failure with normal ejection fraction: a Randomised, Double-Blind, Placebo-Controlled Trial
A clinical trial comparing bronchodilator effects of two drugs,Tiotropium Bromide and Formoterol Fumarate each over 24 hours in subjects with Asthma.
A Randomized, double-blind, crossover, non-inferiority study comparing bronchodilator effects of single dose of 18 mcgg of Tiotropium Bromide and two doses of 12 mcg of
A study evaluating the therapeutic potential of low dose Roxithromycin therapy in patients of stable bronchial asthma.
A study evaluating the therapeutic potential of low dose Roxithromycin therapy in patients of stable bronchial asthma.
A clinical trial to study the lung deposition of a pressurized metered dose inhaler (pMDI)in patients with COPD and Asthma
A gamma scintigraphy study to determine the lung deposition of inhaled aerosolized radiolabeled budesonide/formoterol(200/6mcg)in patients with COPD and Asthma
A study to assess the safety and efficacy of Fondaparinux in unstable angina and non-ST elevation myocardial infarction compared to historical controls
A prospective, single arm, open trial to assess the safety and efficacy of Fondaparinux in patients with unstable angina and non-ST elevation myocardial infarction compared to
40
100
360
3000
A study to assess the safety and efficacy of Fondaparinux in unstable angina and non-ST elevation myocardial infarction compared to historical controls
A prospective, single arm, open trial to assess the safety and efficacy of Fondaparinux in patients with unstable angina and non-ST elevation myocardial infarction compared to
XIENCE V India: XIENCE V Everolimus Eluting Coronary Stent System (EECSS) India Post-Marketing Registry
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) India Post-Marketing Registry
Intek Apollo Paclitaxel Eluting coronary stent study
Clinical success and safety of Intek Apollo coronary drug eluting stent with paclitaxel release in patients with de novo lesion
Series III Run-In Trial: Random comparison of Supralimus(R) with Xience V(TM) in the treatment of patients suffering from new congenital atherosclerosis of
Series III Run-In Trial: A randomized comparison of the Supralimus(R) stent with the Xience V(TM) stent in the treatment of patients with de novo native coronary E-SERIES Registry: Supralimus(R) and
Supralimus-Core(TM) Cardiac Stents for the Treatment of Coronary Artery Blockage.
E-SERIES Registry: A Prospective and Retrospective, Multinational Investigation of the Supralimus(R) and Supralimus-Core(TM) Sirolimus-Eluting Stents for the Treatment of Unselected Patients with Coronary Lesions in the Real-World Clinical
Clinical trial registry database India/WHO
Phase Site 1
Phase 3 1
14 Banker's Heart Institute
Phase 2 6
Phase 3 NA 11
Phase 3 4
Phase 2 16 The Heart Care Clinic
Phase 3 24 PRS Hospital
Phase 3 Years 30
Phase 3 14
Esti trial duration
total Sites no
3 Months Department of cardiology, CMC hospital
Phase 3/Phase 4
2 Years Spandan Heart Institute and Research Center
SAL Hospital & Medical Institute
5 Months Cooper Hospital,
Vileparle(W), Mumbai, [email protected]
21 Months
Tagore Heart Care and Research Centre,
12 Months G. B. Pant Hospital & Maulana Azad Medial
College
Phase 2 Months 15
12
Phase 4 9
2
Phase 3 12
Phase 3 12 ACEER
5
Phase 3 1 IRL Research Centre
Phase 3 40 KEM Hospital
Phase 3 27
Phase 2 7 BYL Nair Hospitak
Deenanath Mangeshkar Hospital & Research
Centre
Phase 2/Phase 3
Amrita Institute of Medical Sciences
Months Escorts Heart Institute and Medical Research
Center
Not Applicable
2 Years Room No. 4046D,
Department of Pharmacology, A.I.I.M.S.
B.M. Birla Heart Research Centre
35 Months
Narayana Hrudayalaya Institute of Medicine
5 Months
4.75 Years
5 Years Nizam's Institute of Medical Sciences
12 Months
Phase 3 40 Care hospitals
3 Dr. Ajay Naik
Phase 4 11 The Heart Care Clinic
8
C-4/3 Vasant Vihar
1
Phase 2 6
Phase 3 11
Phase 3 24
Phase 4 11
1 AIIMS
Phase 3 18
4 Years
Phase 3/Phase 4
5 Years
5.5 Years
Not Applicable
2 Years
Not Applicable
1 Years Department of physiotherapy
2 Years Spandan Heart Institute and Research Center
Years SAL Hospital & Medical Institute
Years Metro Multispeciality Hospital
Months FORTIS FLT. LT. RAJAN DHALL HOSPITAL
Phase 3/Phase 4
2 Years
MGM Medical College & M.Y Hospital
Phase 2 9
1
Phase 3 2
2
Phase 3 30
Phase 3 9
Phase 2 1 PGIMER
Phase 3 1
Phase 4 1
Phase 4 1
Phase 3 1
1 Years S. R. Kalla Memorial Gastro & General Hospital
Not Applicable
12 Months Escorts Heart Institute and Research Center, Okhla Road, New Delhi (India)-110 025
3 Months Apex Superspeciality Hospital
Not Applicable
2 Years Room No. 4046D, Department of Pharmacology, A.I.I.M.S.
43 Months Choithram Hospital & Research Centre
2.5-5 Years Escorts Heart Institute and Research Centre
2 Years
1 Years Chest Research Foundation
Months Chest Research Foundation
45 Days Institute of Nuclear Medicine & Allied Sciences (INMAS)
3 Months Department of cardiology, CMC hospital
Phase 3 1
Phase 4 18
Phase 3 6
Phase 4 15 PRS Hospital
Phase 4 1
3 Months Department of cardiology, CMC hospital
Years Escorts Heart Institute & Research Centre
1 Years Meenakshi Mission Hospital & Research Centre
Years
2 Years Shri B.D. Mehta Mahavir Heart Institute
Clinical trial registry database India/WHO
Site 2 Site 3 Site 4
Heart & General Hospital
CARE Hospital Shri Ram Cardiac Center
Prime Hospital
PGI
Avanti Institute of Cardiology
Spandan Heart Institute & Research Centre
Avanti Institute of Cardiology
narayana Hrudayalaya Institute of Medical
Sciences
5th Floor, Sir Ganga Ram Hospital
Institute of Cardiovascular Diseases
Clinic ,Bhavnagar,[email protected]
K.E.M.Hospital & Seth G.S. Medical
College,Mumbai,[email protected]
Smt. N H L Muni. Medical College,Ahmedabad,Rajp
Department of Cardiology, Life Care Institute of Medical Science and
Research
Total CardioVascular Solutions Pvt. Ltd
Metro Multispeciality Hospital
Meenakshi Mission Hospital and Research
Centre
Dharma Vira Heart Centre
S.R.Kalla Memorial Gastro & General
Hospital
Shri Krishna Hrudayalaya & Critical Care Centre
Cardiac Care & Counseling Center
M S Ramaiah Narayana Hrudalaya,
Wockhardt Heart Hospitals
Grant Medical Foundation CARE Hospital
Ruby Hall Clinic Fortis Hospital
Care Hospital
Sterling Hospital
Osmania General Hospital King George Hospital
Bollineni Ramanaiah Memorial Hospital (P)
Limited
Meenakshi Mission Hospital & Research
Centre
Healing Touch Angiography & Cardiac Surgery Centre, Gupte
Cardiac Care Centre and Hospital
Bangalore Diabetes Hospital
Madras Diabetes Research Foundation
Health and Research Centre
Life Care Institute of Medical Science & Research Centre
Cardiology OPD, Department of Cardiology,
Life Care Institute of Medical Science & Research Centre
Bangalore Diabetes Hospital
Medisys Clinisearch India Pvt Ltd
Kasturba Medical College Hospital
Christian Medical College and Hospital
All India Institute of Medicine
Escorts Heart Institute and Research Centre
Shatabdi Superspeciality Hospital
Department of Medicine, M.G.M. Medical College
and M.Y. Hospital,
Deenanath Mangeshkar Hospital & Research
Center, Dept. of Cardiology
Institute of Cardiovascular Diseases,
Pondicherry Inst of Medical Sciences
Mediciti Hospital Medwin Hospitals
TCVS
CARE Hospital Madras Medical Mission
Heart Care Clinic
Fortis Escorts Hospital
CARE Hospital Shri Ram Cardiac Center
Kasturba Hospital
Deenanath Mangeshkar Hospital
Escorts Heart Institute & Research Centre
Escorts Heart Institute & Research Center
Escort Heart & Research Institute
Avanti Institute of Cardiology
narayana Hrudayalaya Institute of Medical Sciences
5th Floor, Sir Ganga Ram Hospital
Institute of Cardiovascular Diseases
Meenakshi Mission Hospital and Research Centre
Dharma Vira Heart Centre
DAYANAND MEDICAL COLLEGE AND HOSPITAL
S.R. KALLA MEMORIAL HOSPITAL
KING GEORGE HOSPITAL ANDHRA MEDICAL COLLEGE
St. John's Medical College Hospital
G Kuppuswamy Naidu Memorial Hospital
Narayana Hrudayalaya Institute of Medical Sciences
Mediciti Hospitals,
Bankers Heart Institute Care Hospital
TCVS Pvt Ltd Spandan Heart Institute
Dharma Vira Heart Centre
Monilek Hospital & Research Centre
Shree Venkatesh Hospital and Polyclinic
Cardiology OPD, Department of Cardiology,
Health And Research Center
Life Care Institute of Medical Science and Research
Madras Medical Mission Holy Family Hospital Krishna Heart Institute
Madras Medical Mission Wockhardt Heart Hospital
Apollo Hospital Madras Medical Mission
Life Care Institute of Medical Sciences & Research Centre
Shri.Jayadeva Institute of Cardiology
Clinical trial registry database India/WHO
Site 5 Site 6 Site 7
Sir Ganga Ram Hospital,
CARE Hopsitals
Kasturba Hospital Mediciti Hospitals
The Heart Care Clinic Sir Ganga Ram Hospital
Sanjay Gandhi Post Graduate Institute Of
Medical Sciences
Max Devki Devi Heart and Vascular Institute,
Deenanath Mangeshkar Hospital and Research
Centre
Amrita Institute of Medical Sciences
Christian medical College and Hospital
Delhi Heart and Lung Institute
WestFort Hi-Tech Hospital Ltd
A. J. Hospital and Research Centre
Dharma Vira Heart Centre
Health and Research Centre
M.S Ramaih Memorial Hospital
Life Care Institute of Medical Sciences &
Research,
Kovai Medical Centre & Hospital Limited,
Grant Medical Foundation, Ruby Hall
Clinic,
Yasoda Hospital Sanjay Gandhi PGIMS
Hridayam Heart Care V.S. General Hospital
Sir Ganga Ram Hospital
Bhatia Hospital
Bankers Heart Institute
Manipal Hospital
M. S. Ramaiah Memorial Hospital
Jnana Sanjeevini Medical Center
Nizam?s institute of Medical Sciences
Pitale Diabetes & Hormone centre
Department of Cardiology, PRS Hospital
B.M. Birla Heart Research Centre
Kokilaben Dhirubhai Ambani Hospital
Shree Saibaba Heart Institute & Research
Centre
Madras Diabetes Research Foundation
Gokula Metropolis Clinical Research Center
Manipal AcuNova KH Clinical Research Center,
Lifecare Institute of Medical Sciences and
Research
Dande Diabetes and Heart Care Centre
Fortis Escorts Hospital, (A Unit of Escorts Heart and Super Specialty Limited)
Escorts Heart Institute & Research Centre
Rangdore Memorial Hospital
MAMC - Lok Nayak Hospital
Glenmark Cardiac Center Frontier Lifeline
Fortis Hospital, Mohali
Escorts Hospital
Mediciti Hospitals
Omega Hospital
KLES Dr.Prabhakar KORE hospital
Gandhi's Research Institute
Instride Hospital & research centre
Indraprastha Apollo Hospital
Escorts Hospital & Research Center
Deenanath Mangeshkar Hospital and Research Centre
Amrita Institute of Medical Sciences
Christian medical College and Hospital
Delhi Heart and Lung Institute
WestFort Hi-Tech Hospital Ltd
Health and Research Centre
St. John's Medical College and Hospital
HEALTH AND RESEARCH CENTRE
LIFE CARE INSTITUTE OF MEDICAL SCIENCE & RESEARCH
PITALE DIABETES & HORMONE CENTRE
Deenanath Mangeshkar Hospital and Research Centre
Escorts Heart Institute and Research Centre
Kasturba Hospital Wockhardt Heart Hospital
Mediciti Hospital Omega Hospital
Ruby Hall Clinic PSG Hospitals Holy Family Hospital
Crescent Hospital & Heart Centre
Shri Krishna Hrudayalaya & Critical Care Centre
Lissie Hospital
Zynova Heart Hospital
Life Care Institute KEM Hospital
Poona Hospital And Research Centre
SAL Hospital And Medical Institute
Grant Medical Foundation, Ruby Hall Clinic
Jaslok Hospital & Research Centre
Clinical trial registry database India/WHO
Site 8 Site 9 Site 10
Holy Family Hospital
S.P. Medical College
Nanjappa Hospital
Holy Family Hospital
St. Johns Medical College & Hospital
Poona Hospital & Research Centre
St. John's Medical College Hospital
MGM Medical College and MY Hospital
Institute of Cardiovascular Diseases
Cresent Hospital and Heart Centre
St. John's Medical College and Hospital
S. R. Kalla Memorial Gastro & General
Hospital
Baroda Heart Institute & Research Centre
M.V. Hospital and Research Center
SP Medical College & AG Hospitals,
KEM Hospital & Seth GS Medical College,
Dr. Ramesh Cardiac and Multispeciality Hospital
Ltd.,
Institute of Post Graduate Medical Education &
Research,
Apollo Gleneagles
Fortis Hospital Apollo Hospital
V.S. General Hospital Sterling Hospital
KEM Hospital
Ruby Hall Clinic CARE Hospital
CRESCENT HOSPITAL
Avanti Institute of Cardiology
Bhagwan Mahaveer Jain Hear Centre
Samatvam: Endocrinology Diabetes Centre
S.R Kalla Memorial Hospital
Gokula Metropolis Clinical Research Centre
Kamalnayan Bajaj Hospital
Diabetes Care and Research Centre,
CARE Foundation, CARE Hospital
ShreeKrishna Hospital and Heart care centre
Deenanath Mangeshkar Hospital and Research
Centre
Maulana Azad Medical College and Guru Nanak
Eye Centre
Gurunanak CARE Hospital
KEM Hospitals Belgaum Diabetes Centre
Fortis Hospital Medanta- The Medicity Asian Heart Institute
Indraprastha Apollo Hosp
S.P. Medical College
Holy Family Hospital
Bankers Heart Institute,
Bankers Heart Institute Arneja Heart Institute
Health and Research Centre
St. John's Medical College Hospital
MGM Medical College and MY Hospital
S. R. Kalla Memorial Gastro & General Hospital
Indraprastha Apollo Hospitals
Jnana Sanjeevini Medical Center
Krishna Institute of Medical Sciences
Crescent Hospital & Heart Centre
Osmania Medical College
Bisne Heart Hospital Ruby Hall Clinic
Artemis Health Institute
L.T.M.M College & Hospital
Sri Gokulam Medical College & Research Foundation
Max Devki Devi Heart and Vascular Institute
Apollo Hospital Christian Medical College
Ruby Hall Clinic
Dayanand Medical College & Hospital
B.M.Birla Heart Research Center
Escorts Heart Institute & Research Centre
Clinical trial registry database India/WHO
Site 11 Site 12 Site 13
Sterling Hospital,
CRESCENT HOSPITAL
TCVS Pvt. Ltd Heart & General Hospital Apollo Hospitals
Care Hospital,
Krishna Heart & Super Specialty Institute
Krishna Institute of Medical Sciences
3-MM II, Panchkuian Road
Sri Venkateswara Institute of Medical Sciences
J.S.S. Hospital and Medical College
Sangini Hospital, Neonatal, Padiatric &
Adult Intensive Care Units
Indraprastha Apollo Hospitals
Dr. Kamakshi Memorial Hospital
Apollo Gleneagles Hospitals Ltd
All India Institute of Medical Sciences,
King George Hospital
Sterling Hospital
Care Hospital Bankers Heart Institute
The Heart Care Clinic Fortis Hospital Mediciti Hospitals
Poona Medical Research Foundation
Krishna Heart & Superspeciality Institute
St. John's Medical College Dept. of cardiology
Diabetes Thyroid Hormone Research
Institute
Krishna Institute of Medical Sciences
Dande Diabetes & Heart Care Centre, Maternity &
Nursing Home,
M.V.Hospital for diabetes and Diabetic Research
Centre
St. Johns Medical College and Hospital
KMC Hospital St Johns Medical College
Christian Medical College
CRESCENT HOSPITAL
Omega Hospital
KEM Hospital
Bangalore Endocrinology and Diabetes Research
centre
Deenanath Mangeshkar Hospital & Research Centre
Dr. Kamakshi Memorial Hospital
SHRIKRISHNA HRUDAYALAYA AND CRITICAL CARE
Poona Hospital and Research Centre
Amrita Institute of Medical Sciences
Nimit Matra HospitalHeart First Cardiac and Vascular Clinic
Shree Sai Baba Heart Institute and Research Center
Fortis HospitalEscorts Heart & Superspeciality Institute Ltd.
Max Devki Devi Heart & Vascular Institute
Kailash Health Care Limited
Sanjay Gandhi Post Graduate Institute of Medical Sciences
Max Devki Devi Heart and Vascular Institute
Clinical trial registry database India/WHO
Site 14 Site 15 Site 16
The Heart Care Institute,
Radiance Hospital Arneja Heart Institute
Care Hospital,
Aditya Hospital & Critical Care Unit
SHRIKRISHNA HRUDAYALAYA AND
CRITICAL CARE
ARNEJA HEART INSTITUTE,
BISNE HOSPITAL PVT LTD
Monilek Hospital And Research Centre
Deenanath Mangeshkar Hospital and research
center,
Grant Medical Foundation, Ruby Hall Clinic, 40, Sasoon Road,
Pune - 411001
Heart Care Clinic Narayana Hrudayalaya
Sir Ganga Ram Hospital Omega Hospital Pvt. Ltd.
Fortis Escorts Hopsital
Meenakshi Mission Hospital and Research
Centre
Apollo Hospitals International Ltd
Dept. of Cardiology, Dharma Vira Heart
Centre,
JSS Hospital Ruby Hall Clinic
Mediciti Hospitals Frontier Lifeline Pvt Ltd
Poona Hospital and Res Centre
ARNEJA HEART INSTITUTE,
BISNE HOSPITAL PVT LTD
AVANTI INSTITUTE OF CARDIOLOGY PVT. LTD
Krishna Institute of Medical Sciences
Metro Multispeciality Hospital
Dharam Vira Heart Centre
Bhanubhai & Madhuben Patel Cardiac Centre
Jehangir Hospital CARE Hospital Heart & General Hospital
All India Institute of Medical Sciences
Escorts Heart Institute & Research Centre
Clinical trial registry database India/WHO
Site 17 Site 18 Site 19
RUBY HALL CLINIC K.E.M HOSPITAL,AVANTI INSTITUTE OF
CARDIOLOGY PVT. LTD
Lifecare Institute of Medical Sciences &
Research,
Escorts Heart Institute and Research Center,
Okhla Road, New Delhi - 110025
"Patiala Heart Institute, 2- Jagdish Marg, Patiala-147
001 (Punjab) India
Osmania Medical College
Sterling Hospital
Dayanand Medical College and Hospital
S R Kalla Memorial Gastro and General
Hospital
Cardiology Department, Sadbhavna Medical &
Heart Institute
Krishna Institute of Medical Sciences,
BGS Global Hospital
RUBY HALL CLINIC K.E.M HOSPITAL,
Lakeshore Hospital and Res Ctr
Narayana Hrudayalaya Institute of medical
sciences
DEENANATH MANGESHKAR HOSPITAL & RESEARCH CENTRE
Sri Jayadeva Institue of Cardiology
Kovai Medical Center and Hospital Limited
Deep Heat CentreBhanubhai & Madhuben Patel Cardiac Centre
Choithram Hospital & Research Centre
Escorts Heart Institute & Research Centre
Krishna Institute of Medical Sciences
Clinical trial registry database India/WHO
Site 19 Site 20 Site 21
DEENANATH MANGESHKAR
HOSPITAL & RESEARCH CENTRE
NARAYANA HRUDAYALAYA INSTITUTE OF
MEDICAL SCIENCES
KOVAI MEDICAL CENTER AND
HOSPITAL LIMITED
Vikram Hospital & Heart Care, #46, Vivekananda
Road, Yadavagiri, Mysore-570020 Karnataka
G. Kuppuswamy Naidu Memorial Hospital,
Narayana Hrudayalaya, 258/A- Bommasandra
Industrial Area, Anekal Taluk, Bangalore-560 099
Karnataka
Kovai Medical Centre
Apollo Hospitals Fortis Hospital,
Christian Medical College and Hospital
West Fort Hi-tech Hospital
Medanta -The Medicity, Medanta Heart Institute,
Asian Heart Institute
Yashoda Hospital
Global hospital & health city
Jnana Sanjeevini Med Centre
NARAYANA HRUDAYALAYA INSTITUTE OF MEDICAL SCIENCES
KOVAI MEDICAL CENTER AND HOSPITAL LIMITED
JSS Medical College Kalcadiya HospitalLife Care institiute of Medical Science &Research
Clinical trial registry database India/WHO
Site 22 site 23 Site 24
Yashoda Hospital Sanjivani Super Speciality Hostpital,
Holy Family Hospital, St. Andrew's Road, Bandra (West) Mumbai-400050
Maharashtra
Nanjappa Hospital, 660, Kuvempu Road, Shimoga-
577201 Karnataka
Mediciti Hospitals, 5-9-22, Secretriat Road,
Hyderabad- 500063 Andhra Pradesh
Holy Family Hospital Yashoda group of HospitalRamesh Cardiac and
Multi Speciality Hospital Ltd.
Fortis Flt. Lt. Rajan Dhall Hospital
Sanjay Gandhi Postgraduate Institute of
Medical Sciences
CARE Hospital (Visakha Hospitals & Diagnostics Ltd.) A.S. Raja Complex
PRS Hospital
Amrita Institute of Med Sci
MSRamaiah Narayana Hurdyalaya
Mahavir Hospital and Research Centre
Sanjivani Super Speciality Hostpital,
Indus Hospital JSS Medical College Fortis Malar Hospital
Clinical trial registry database India/WHO
Site 25 Site 26 Site 27
Dr Ramesh Cardiac & Multispeciality Hosp. Ltd.,
Fortis Escorts HospitalJLN Marg,
Malviya NagarJaipur-302 017Rajasthan
Avanti Institute of Cardiology, 5- Abhyankar Road, Dhantoli, Nagpur-
440012 Maharashtra
Care Hospital Mediciti HospitalNarayanan Hrudayalaya
Institute of Medical Sciences
Fortis Escorts Hospital and Research Centre
Lotus diagnostic Centre Artemis Health InstituteLife Care Institute of Medical Sciences
Osmania Medical College Wockhardt Heart HospitalLittle Flower Hospital And Research Centre
Clinical trial registry database India/WHO
Site 28 Site 29 Site 30
Shri Sai Baba Heart Institute & Research
Centre,
"Hope Specialty Hospital, 200- W K Road, Meerut ?
250001 Uttar Pradesh, India.
P R S Hospital Frontier Lifeline HospitalP S Medical College and Shree Krishna Hospital
The Heart Care Clinic Yashoda Super Speciality Hospitals
Krishna Institute of Medical Sciences
St. Isabels HospitalVijan Cardiac & Critical Care Centre
Clinical trial registry database India/WHO
Site 31 Site 32 Site 33
Medwin Hospitals Tagore Heart Care and Research Centre
Shree Saibaba Heart Institute and Research
Centre
Endocrinology Diabetes Center
Inst of Post Grad Med Ed Res
City Diagnostics WE-LINK SMO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
Clinical trial registry database India/WHO
CTRI No.and Date
Trial 1 11/18/2008
Trial 2 8/22/2008
Trial 3 1/25/2008
Trial 4 Completed 3/27/2008
Trial 5 4/24/2008
Trial 6 4/30/2008
Trial 7 4/30/2008
Trial 8 6/30/2008
Trial No.
UTRN.WHO Status of TrialWHO
Last Verified on
TEMP UTRN 050440745-11112008346614
CTRI/2008/091/000248, 18-11-2008
Closed to recruitment of participants
TEMP UTRN 041851255-0201200863215
CTRI/2008/091/000001, 22-08-2008
Open to recruitment
TEMP UTRN 020846127-2001200876203
CTRI/2008/091/000010, 25-01-2008
Not yet recruiting
TEMP UTRN 051429058-3101200880234
CTRI/2008/091/000014, 27-03-2008
TEMP UTRN 024151995-11042008115187
CTRI/2008/091/000040, 24-04-2008
Open to recruitment
TEMP UTRN 111501559-22042008122327
CTRI/2008/091/000047, 30-04-2008
Not yet recruiting
TEMP UTRN 033022512-25042008129327
CTRI/2008/091/000054, 30-04-2008
Not yet recruiting
TEMP UTRN 080401529-23052008146368
CTRI/2008/091/000070, 30-06-2008
Closed to recruitment of participants
Trial 9 Completed 7/15/2008
Trial 10 6/9/2008
Trial 11 6/19/2008
Trial 12 Completed 7/21/2008
Trial 13 Completed 11/5/2008
Trial 14 9/25/2008
Trial 15 11/3/2008
Trial 16 9/11/2009
TEMP UTRN 024223858-26052008147187
CTRI/2008/091/000071, 15-07-2008
TEMP UTRN 105621713-28052008150129
CTRI/2008/091/000074, 09-06-2008
Open to recruitment
TEMP UTRN 114513161-09062008173164
CTRI/2008/091/000087, 19-06-2008
Open to recruitment
TEMP UTRN 115010744-30062008188406
CTRI/2008/091/000099, 21-07-2008
TEMP UTRN 040444495-10072008203420
CTRI/2008/091/000112, 05-11-2008
TEMP UTRN 120312396-21092008274557
CTRI/2008/091/000179, 25-09-2008
Open to recruitment
TEMP UTRN 102550127-1609200826427
CTRI/2008/091/000169, 03-11-2008
Closed to recruitment of participants
TEMP UTRN 070651232-2909200828648
CTRI/2008/091/000191, 11-09-2009
Open to recruitment
Trial 17 Completed 6/4/2009
Trial 18 11/17/2008
Trial 19 Completed 1/12/2009
Trial 20 Terminated 11/28/2008
Trial 21 12/12/2008
Trial 22 Completed 1/28/2010
Trial 23 Completed 12/22/2008
Trial 24 Completed 12/22/2008
Trial 25 Completed 2/3/2009
TEMP UTRN 122846831-08102008298602
CTRI/2008/091/000201, 16-06-2009
TEMP UTRN 103511148-13102008303620
CTRI/2008/091/000206, 17-11-2008
Open to recruitment
TEMP UTRN 113712877-29102008323509
CTRI/2008/091/000226, 12-01-2009
TEMP UTRN 024937708-19112008352605
CTRI/2008/091/000254, 28-11-2008
TEMP UTRN 115109450-08122008374753
CTRI/2008/091/000276, 12-12-2008
Closed to recruitment of participants
TEMP UTRN 111643947-15122008386609
CTRI/2008/091/000286, 28-01-2010
TEMP UTRN 110159200-19122008397753
CTRI/2008/091/000295, 22-12-2008
TEMP UTRN 124557766-19122008398753
CTRI/2008/091/000296, 22-12-2008
TEMP UTRN 024511826-07012009424529
CTRI/2009/091/000012, 03-02-2009
Trial 26 Completed 9/3/2009
Trial 27 10/13/2009
Trial 28 Completed 6/9/2010
Trial 29 Completed 9/24/2009
Trial 30 3/4/2009
Trial 31 Terminated 29-05-2009
Trial 32 4/5/2009
Trial 33 15-04-2009
Trial 34 16-04-2009
TEMP UTRN 071004305-100320095101078
CTRI/2009/091/000091, 03-09-2009
TEMP UTRN 052227973-28012009460856
CTRI/2009/091/000043, 13-10-2009
Open to recruitment
TEMP UTRN 011740523-02042009581207
CTRI/2009/091/000161, 09-06-2010
TEMP UTRN 071031378-13022009485959
CTRI/2009/091/000068, 24-09-2009
TEMP UTRN 090552197-230220094951008
CTRI/2009/091/000078, 04-03-2009
Open to recruitment
TEMP UTRN 035024123-130320095181087
CTRI/2009/091/000098, 29-05-2009
TEMP UTRN 075313930-190320095241079
CTRI/2009/091/000104, 04-05-2009
Open to recruitment
TEMP UTRN 045133155-25032009539178
CTRI/2009/091/000119, 15-04-2009
Open to recruitment
TEMP UTRN 020607659-260320095431032
CTRI/2009/091/000123, 16-04-2009
Closed to recruitment follow up continuing & closed to recruitment
Trial 35 31-03-2009
Trial 36 15-05-2009
Trial 37 27-05-2009
Trial 38 25-05-2009
Trial 39 4/5/2009
Trial 40 29-05-2009
Trial 41 10/7/2009
Trial 42 6/7/2009
Trial 43 20-08-2009
TEMP UTRN 042715053-26032009545874
CTRI/2009/091/000125, 31-03-2009
Closed to recruitment of participants
TEMP UTRN 124132731-220420096201211
CTRI/2009/091/000200, 15-05-2009
Open to recruitment
TEMP UTRN 033519060-150520097221180
CTRI/2009/091/000279, 27-05-2009
Open to recruitment
TEMP UTRN 052322236-150520097241180
CTRI/2009/091/000281, 25-05-2009
Open to recruitment
TEMP UTRN 114448674-240420096301078
CTRI/2009/091/000210, 04-05-2009
Closed to recruitment of participants
TEMP UTRN 030046461-270420096371165
CTRI/2009/091/000217, 29-05-2009
Closed to recruitment of participants
TEMP UTRN 061236763-150620098211532
CTRI/2009/091/000371, 10-07-2009
Open to recruitment
TEMP UTRN 040237171-200620098661475
CTRI/2009/091/000409, 06-07-2009
Closed to recruitment of participants
TEMP UTRN 111803469-22062009869178
CTRI/2009/091/000412, 20-08-2009
Closed to recruitment of participants
Trial 44 11/8/2009
Trial 45 21-07-2009
Trial 46 15-07-2009
Trial 47 23-07-2009
Trial 48 Terminated 17-08-2009
Trial 49 Completed 12/8/2009
Trial 50 9/9/2009
Trial 51 27-07-2009
Trial 52 Completed 9/12/2009
Trial 53 3/12/2009
TEMP UTRN 025630079-0108200910731078
CTRI/2009/091/000608, 11-08-2009
Open to recruitment
TEMP UTRN 024238822-300620099461444
CTRI/2009/091/000484, 21-07-2009
Closed to recruitment of participants
TEMP UTRN 100400826-030720099641332
CTRI/2009/091/000501, 15-07-2009
Closed to recruitment of participants
TEMP UTRN 110506197-060720099761734
CTRI/2009/091/000513, 23-07-2009
Closed to recruitment of participants
TEMP UTRN 110034575-09072009999235
CTRI/2009/091/000536, 17-08-2009
TEMP UTRN 045906401-080720099951735
CTRI/2009/091/000532, 12-08-2009
TEMP UTRN 032227767-0707200999036
CTRI/2009/091/000527, 09-09-2009
Open to recruitment
TEMP UTRN 100057840-08072009991744
CTRI/2009/091/000528, 27-07-2009
Open to recruitment
TEMP UTRN 050249236-090720091000859
CTRI/2009/091/000537, 09-12-2009
TEMP UTRN 093248354-1307200910091643
CTRI/2009/091/000546, 03-12-2009
Open to recruitment
Trial 54 30-07-2009
Trial 55 18-08-2009
Trial 56 Completed 3/9/2009
Trial 57 29-01-2010
Trial 58 13-08-2009
Trial 59 24-09-2009
Trial 60 Completed 22-09-2009
Trial 61
Trial 62
TEMP UTRN 093633152-1407200910151032
CTRI/2009/091/000552, 30-07-2009
Open to recruitment
TEMP UTRN 054935881-290720091062602
CTRI/2009/091/000598, 18-08-2009
Open to recruitment
TEMP UTRN 032906743-150720091023832
CTRI/2009/091/000560, 03-09-2009
TEMP UTRN 114055429-2507200910541835
CTRI/2009/091/000590, 29-01-2010
Not yet recruiting
TEMP UTRN 105551367-1008200910971032
CTRI/2009/091/000632, 13-08-2009
Open to recruitment
TEMP UTRN 094148451-110820091102602
CTRI/2009/091/000636, 24-09-2009
Open to recruitment
TEMP UTRN 073509822-160820091124832
CTRI/2009/091/000656, 22-09-2009
Trial 63
Trial 64
Trial 65
Trial 66
Trial 67
Trial 68
Trial 69
Trial 70
Trial 71
Trial 72
Trial 73
Trial 74
Trial 75
Trial 76
Trial 77
Trial 78
Trial 79
Trial 80
Trial 81
Trial 82
Clinical trial registry database India/WHO
Phase
9/14/2009 Diabetic 1 Phase 4
8/21/2008 Diabetic 8600 Phase 3
1/24/2008 Diabetic 200
7/17/2009 Diabetic Phase 3
7/1/2008 Diabetic 500 Phase 3
1/1/2007 Diabetic 180 Phase 2
1/1/2007 Diabetic 60 Phase 2
5/21/2010 Diabetic 200 Phase 4
Last Updated on
Speciality-Subspeciality
Public Title StudyWHO*
Scientific Title of StudyWHO*
T. sample
sizeTo compare the efficacy and safety of a new formulation of telmisartan with the currently available formulation in the
A Randomized, Two Arm, Open Label, Comparative, single centre study to evaluate efficacy and safety of 2 generic formulations of
ALiskiren Trial In Type 2 diabetes Using cardiorenal Disease Endpoints
A randomized, double-blind, placebo-controlled, parallelgroup study to determine whether, in patients with type 2 diabetes at
A clinical trial to study the existence of reduced nerve mobility in old age individuals, comparing diabetic and non-diabetic subjects
Prevalence of Adverse Neural Tension in Geriatric Population With and Without Diabetes Mellitus- Study of Responses Elicited
Phase of Trial*
Effect of liraglutide or glimepiride added to metformin on blood glucose control in subjects with type 2 diabetes
Effect of liraglutide or glimepiride added to metformin on glycaemic control in subjects with type 2 diabetes
A Glycemic Control Evaluation of Glimepiride versus Rimonabant on Top of Metformin in Type 2 Diabetes
A Randomized, Double-Blind, Parallel-Group, Multicenter, Multinational Study to Assess Glycemic Control with Rimonabant in Comparison with
A clinical trial to study the effects of 2 Ayurvedic formulations, containing Ashwagandha, Brahmi and Amalaki on the physical and emotional well-being of elderly
A Proof of Concept prospective, double-blind, placebo controlled, comparative, randomized, parallel group, multi-centric clinical study to evaluate short-term
A clinical trial to study safety and activity of Ayurvedic formulation containing Ashwagandha and Haridra in patients with Type 2 Diabetes
A Proof of Concept prospective, double blind, placebo controlled, randomized, multi-¬centric study to evaluate the safety and activity of PHP-Diabetes
A clinical trial to assess the frequency of "low sugar" in the mother with elevated sugars (during pregnancy) using insulin aspart.
An open-label, prospective study to observe the incidence of hypoglycemia with insulin aspart in pregnant women with any degree of
7/2/2010 Diabetic Phase 3
6/3/2008 Diabetic 60 Phase 2/Phase 3
3/5/2010 Diabetic Phase 2/Phase 3
11/21/2009 Diabetic 42 Phase 4
11/4/2008 Diabetic 40 Phase 1/Phase 2
9/9/2009 Diabetic Phase 4
7/27/2009 Diabetic Not Applicable
9/2/2009 Diabetic 500 Phase 3
A clinical trial to study the efficacy and safety of AVE0010 in patients with type 2 diabetes not treated with antidiabetic agents
A randomized, double-blind, placebo-controlled, parallel-group, multicenter 12-week study assessing the efficacy and safety
Role of a probiotic, VSL#3, in patients with nonalcoholic fatty liver disease.
Small intestine bacterial overgrowth and role of probiotic, VSL#3 in patients with nonalcoholic fatty liver disease
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD) (VIEW 2)
A randomized, double masked, active controlled, phase 3 study of the efficacy, safety, and tolerability of repeated doses of intravitreal VEGF Trap-
A clinical trial to study the effect of atorvastatin on pancreatic beta-cell function & insulin resistence in patients
A randomized double-blind placebo-controlled prospective evaluation of the effect of atorvastatin on pancreatic beta-cell
Effect of high dose vitamin B1 on early stage kidney disease in type 2 diabetes
A randomised, double-blind, placebo-controlled study to assess if high dose thiamine therapy of type diabetic patients
Evidence of Good Glycemic control in Conceptions through Assisted Reproduction Technology [EGG CART Study]
A Prospective, Monocentric, Open labelled, Multiple arm study on the influence of strict periconception glycemic control in women with various degrees of glucose intolerance in the
A clinical study to assess the effects of two drugs, atorvastatin and pioglitazone in patients of high blood pressure or angina, but
Effects of Atorvastatin and Pioglitazone on Endothelial Dysfunction in non-diabetic patients with hypertension or stable angina
Pilot Study Targeting Normal Glucose in Patients with Acute Myocardial Infarction through appropriate use of insulin therapy.
REsearching Coronary REduction by Appropriately Targeting Euglycemia ( Pilot Study): An International Multicentre Randomized Controlled Trial of Intensive Insulin
6/16/2009 Diabetic Phase 3
11/14/2008 Diabetic 100 Not Applicable
4/1/2009 Diabetic Phase 3
1/15/2009 Diabetic
6/14/2010 Diabetic Phase 3
1/29/2010 Diabetic 600 Phase 3
12/3/2009 Diabetic 10 Phase 2
12/3/2009 Diabetic Phase 2
4/6/2010 Diabetic Phase 2
Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes
A multicenter, double-blind, randomized, active controlled study to compare the effect of 52 weeks treatment with LAF237 50 mg bid to gliclazide up to 320 mg daily as add-on therapy in patients with type 2 diabetes
A clinical study to evaluate effect of surgery for control of Type2 diabetes in overweight individuals
A clinical trial of surgical treatment of Type2 Diabetes in non morbidly obese patients.
A clinical study to compare effects and safety Of recombinant Insulin Glargine manufactured by Biocon Ltd Compared to marketed Glargine
Open Label, Randomized, Multicentric Study To Establish Safety And Efficacy Of Recombinant Insulin Glargine Manufactured By Biocon
A clinical study to study the effects of the drug TZP-101 in patients with severe gastroparesis (delayed gastric emptying)due to Diabetes Mellitus
A Multicenter, Randomized, Double-Blind, Placebo-Controlled,Dose-Ranging Study to Assess the Efficacy and Safety of TZP-101 when
A clinical trial to study the blood sugar lowering effects and safety of oral insulin (IN-105 tablets) in patients of type 2 Diabetes Mellitus.
A Multicenter, Randomized, Double-Blind, Placebo Control Study of IN-105 tablets [oral insulin] in Patients with Type 2 Diabetes Mellitus who have
To assess the anti-diabetic effect of Vijayasar (extract of heartwood of - Pterocarpus marsupium) in the
Extended multicentric trial of Vijayasar (Pterocarpus marsupium) in the management of Type 2 Diabetes Mellitus.
A clinical trial to study the safety and effectiveness of a monoclonal antibody in combination with methotrexate in
A Randomized, Open label, Four Arms Parallel Study to Evaluate the Safety and Efficacy of anti-CD6 monoclonal antibody (T1h mAb) in
A clinical trial to study the safety and efficacy of a monoclonal antibody in patients with active psoriasis
A Phase II Study to Evaluate the Safety and Efficacy of anti-CD6 monoclonal antibody (T1h mAb) in Patients with Active Psoriasis.
A clinical trial to study the effects of 2 herbal products as dietary supplements for Male Sexual Health
A triple blind, randomized, double dummy, prospective placebo controlled dose determination study to investigate the safety and efficacy of E-MA-H
4/15/2010 Diabetic Phase 2
6/25/2010 Diabetic 300 Phase 2
6/14/2010 Diabetic 444 Phase 4
7/27/2009 Diabetic 86 Phase 2/Phase 3
9/8/2009 Diabetic Phase 3
10/6/2010 Diabetic 274 Phase 3
30-04-2009 Diabetic 100 Not Applicable
19-06-2009 Diabetic Phase 3
4/8/2009 Diabetic Phase 3
A Study for Patients With Type 2 Diabetes Mellitus
A 12-Week,Double-Blind, Placebo-Controlled Trial of LY2428757 in Patients With Type 2 Diabetes Mellitus
A Phase II clinical trial to study the effects of TRC4186, an investigational new drug in patients with stable heart failure associated with type 2 diabetes mellitus receiving oral anti-
Safety and Efficacy of TRC4186 in the treatment of stable heart failure associated with HbA1 ≥ 6.5% or type 2 Diabetes receiving oral hypoglycaemic therapy (with or without
Effect of insulin detemir and insulin glargine on blood glucose control in subjects with type 2 diabetes
A 26 week randomised, multinational, open labelled, 2 armed, parallel group, treat-to-target once daily treatment trial with insulin detemir versus
"The effectiveness of a behavioral change communication model in promoting physical activity among females with typeII Diabetes
"The effectiveness of a behavioral change communication model in promoting physical activity among females with typeII Diabetes
A clinical trial to study the effects of Ralfinamide in patients with chronic neuropathic low back pain.
EFFICACY AND SAFETY OF TWO FIXED DOSES (160 OR 320 MG/DAY) OF RALFINAMIDE IN PATIENTS WITH CHRONIC NEUROPATHIC LOW BACK PAIN. A
A clinical trial to study safety and efficacy of two drugs Insugen® R and Insugen® N with Actrapid® and Insulatard® in Patients with Type 1 Diabetes Mellitus.
A Randomized, Active Controlled, Parallel Group, Multi-Center, Two Stage, Open Label, Study Comparing Safety and Immunogenicity of Insugen® R and Insugen® N with
A randomized double blind active controlled parallel clinical trial to compare the effect of exercises(yogic/walking) on serum insulin level
The effect of various exercises yogic/walking on serum insulin level and glycemic control in patients with type 2 diabetes
Randomized, db, Placebo-Controlled 18 Week Study of BI 1356 in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a
A Randomized, Double-Blind, Placebo-Controlled Parallel Group Efficacy and Safety Study of BI 1356 (5 mg Administered Orally Once Daily) Over
Efficacy and Safety Study of Alogliptin Compared to Glipizide in Elderly Diabetics
A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly
13-01-2010 Diabetic 792 Phase 3
10/9/2009 Diabetic Phase 4
26-05-2009 Diabetic 72 Phase 2
1/1/2007 Diabetic Phase 2
15-04-2010 Diabetic 240 Phase 4
24-03-2010 Diabetic Phase 3
30-06-2009 Diabetic 120 Phase 2
10/5/2010 Diabetic 150 Phase 4
11/8/2009 Diabetic 500 Phase 3
A clinical Trial to compare the effects and safety of different combinations of the trial drug and metformin over 24 weeks in drug naïve or previously treated (after with
A phase III randomised, double-blind, placebo-controlled parallel group study to compare the efficacy and safety of twice daily administration of the free combination of BI
A comparison of various antioxidant preparations on insulin sensitivity in Type 2 diabetes patients
A study of comparative effects of Antioxidants on Insulin Sensitivity in type 2 diabetes mellitus: A Randomized Double Blinded Placebo-
A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary
A Phase 2a, Randomized, Double Blind, Placebo-Controlled, Parallel Group Study Investigating The Dose-Response Of PF-00489791 On Acute
A Study Evaluating Efficacy And Safety Of PF-04523655 Versus Laser In Subjects With Diabetic Macular Edema (DEGAS)
A Phase II Prospective, Randomized, Multi-Center, Diabetic Macular Edema Dose Ranging, Comparator Study Evaluating the
A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic
A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic
Evaluate Efficacy and Safety of Saxagliptin in Adult Indian Patients with Type 2 Diabetes inadequate glycemic control.
A 24-Week National, Multi-centre, Randomized, Parallel-group, Double-blind, Placebo-controlled, Phase IIIb study in India to Evaluate the Efficacy
Oral Insulin study for Type 2 Diabetes Mellitus
A Phase 2b, comparative, two arm randomized, placebo-controlled, double blinded multi-centric study to Evaluate the Safety, Tolerability, and
Infinnium-Core(TM) Registry: To Study the Saftey and efficacy of Infinnium-Core(TM) Coronary Stent for the treatment of New
Infinnium-Core(TM) Registry: Safety and Efficacy of the Infinnium-Core(TM) Paclitaxel-Eluting Coronary Stent System
A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and a
A Randomized, Double-Blind, Parallel-Group, Multicenter Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide
6/1/2010 Diabetic 680 Phase 3
30-11-2009 Diabetic Phase 3
14-07-2009 Diabetic 450 Phase 3
14-04-2010 Diabetic 20 Phase 2/Phase 3
30-06-2010 Diabetic 550 Phase 3
7/8/2009 Diabetic 36 Phase 3
20-01-2010 Diabetic 120 Phase 3
27-07-2009 Diabetic 330 Phase 3
14-01-2010 Diabetic Phase 2/Phase 3
26-05-2010 Diabetic 146 Phase 2
A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects
A Comparator-Controlled Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control (HbA1c) and Safety in Asian Subjects
Safety and Efficacy of Albiglutide in Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With
Long-Term Safety Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus
An Open Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety of Dutogliptin / PHX1149T in Subjects with Type 2
A clinical trial to evaluate the safety and efficacy of ReliDerm®DT in patients of non healing diabetic foot ulcer
To study the safety and efficacy of ReliDerm®DT in patients with chronic diabetic foot ulcer
Effects of Naturlose (Tagatose) on blood sugar Control and Safety of Naturlose Over One Year in Subjects with Type 2
Effects of Naturlose (Tagatose) on blood sugar Control and Safety of Naturlose Over One Year in Subjects with Type 2
Effect of Naturo fruit bars in type-II diabetes mellitus
Evaluation of the effect of Naturo fruit bars in patients with type-II diabetes mellitus
A clinical trial to study the safety and efficacy of 2mg and 4mg of ZYH1 compared to Pioglitazone 45mg in dyslipidemia with type 2
A multi-centric, randomized, double blind study to evaluate the safety and efficacy of 2mg and 4mg of ZYH1 compared to
A clinical trial to compare effect of Travoprost APS to TRAVATAN in patients with open-angle glaucoma or ocular
A multi-center, double-masked study of the safety and efficacy of Travoprost APS compared to TRAVATAN in patients with open-
A clinical trial to study the effect of prophylactic intravenous calcium in preventing neonatal early onset
Efficacy of prophylactic intravenous calcium administration in first 5 days of life in high risk neonates to prevent early onset neonatal
Study with HO/03/03 in the treatment of Plantar Neuropathic Diabetic Foot Ulcer.
Safety and efficacy of HO/03/03 in the treatment of Planatar Neuropathic Diabetic Foot Ulcers.
23-02-2010 Diabetic Phase 3
7/1/2010 Diabetic Phase 2
4/9/2009 Diabetic 26 Phase 2
22-01-2010 Diabetic 20 Not Applicable
2/12/2009 Diabetic 1 Phase 2
12/11/2009 Diabetic Phase 2/Phase 3
31-08-2009 Diabetic 26 Phase 2
Efficacy and Safety of Alogiptin plus Metformin Compared to Glipizide plus Metformin in Subjects with Type 2 Diabetes Mellitus.
A Multicenter, Randomized, Double-Blind, Active ? Controlled Study to Evaluate the Durability of the Efficacy and Safety of Alogliptin Compared to Glipizide
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
A 12-week multi-center, randomized, double-blind, placebocontrolled, parallel-group adaptive design study to
Evaluation of Safety and Efficacy of Mersina, an Ayurvedic formulation: A double blind, placebo controlled study in type 2 diabetic patients with
Evaluation of Safety and Efficacy of Mersina, an Ayurvedic formulation: A double blind, placebo controlled study in type 2 diabetic patients with
Clinical trial to study the safety and efficacy of stemcell therapy in patients with heart diseases
Stem cell therapy- Cellular Cardio myoplasty for patients with heart diseases
A clinical trial to study the effects of Naturlose (Tagatose) in patients with mild type 2 Diabetes Mellitus under control with Diet and Exercise over a period
Dose Ranging Effects of Three Low-doses of Naturlose? (Tagatose) on Glycemic Control and Safety of Naturlose? (Tagatose) Over Six Months in
Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients
Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration for the Treatment of Hyperglycemia in Metformin Monotherapy Treated Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of an Ayurvedic
Formulation Limit for safety and efficacy in type 2 diabetic patients with oral drug failure
Evaluation of Safety and Efficacy of Limit, an Ayurvedic formulation: A double blind, placebo controlled study in type 2 diabetic patients with
Site 1 Site 2 Site 3 Site 4
1
20
1
25 Lakshmi Hospital, Lakeshore Hospital
2 Diacon Hospital
4
4
1
Esti trial duration
total Sites no
Years Shree Hari Diabetes Foundation
4 Years Poona Hospital & Research Centre,
Christian Medical College
Madras Diabetic Research Foundation
Topiwala National Medical College & BYL Nair Hospital
2 Years Dept of Physiotherapy
Months Kerala Institute of Medical Sciences (KIMS)
M.V.Diabetes Care & diabetes Research Centre
1 Years Medisys Clinisearch India PVT Ltd
12 Months TNMC & BYL Nair Hospital, Mumbai Central, Mumbai 400 008
Seth G.S. Medical College & KEM Hospital, Parel, Mumbai 400 012
Deccan College of Medical Sciences & Allied hospitals,Kanchanbhag Santoshnagar,Hyderabad-500058
Vydehi Institute of Medical Science and Research Centre, 82, EPIP area, Whitefield. Bangalore-560006
12 Months TNMC & BYL Nair Hospital, Mumbai Central, Mumbai 400 008
Seth G.S. Medical College & KEM Hospital, Parel, Mumbai 400 012
Vydehi Institute of Medical Science and Research Centre, 82, EPIP area, Whitefield. Bangalore-560 00
Deccan College of Medical Sciences & Allied hospitals,Kanchanbhag Santoshnagar,Hyderabad-500058
3 Years MADHAV DIABETES CENTRE
4 Manipal Hospital
2 Dept. of Hepatology
15
1
1
1 Prashanth Hospital
2
17 Nanjappa Hospital
Diabetes Thyroid Research Institute Pvt Ltd
Bhagwan Mahaveer Jain Hospital
Medilink Research Centre
3 Years Dept. of Gastroenterology and HNU, AIIMS
Years Aravind Eye Hospital
Dr.R.P Center for Ophthalmic Sciences
Aravind Eye Hospital
Aravind Eye Hospital
12 Months OPD, Department of Endocrinology & Metabolism, AIIMS, New Delhi
5 Months Sheikh Zayed Federal Postgraduate Medical Institute
4 Years
Months All India Institute of Medical Sciences
All India Institute of Medical Sciences
2 Years Department of Cardiology, St. Johns Medical College & Hospital
Fortis Escorts Hospital
Southern Railway HQ Hospital
8
1 Bombay Hospital
15
1
16 Diacon Hospital
4
10
9 Manipal Hospital Bowring Hospital PSG Hospital
6
Years S. R. Kalla Memorial Gastro & general Hospital
M.S. Ramaiah Memorial Hospital
Christian Medical College,
Nizam's Institute of Medical Sciences
3 Years
Months Samatvam Endocrinology Centre,No:2 , First A Cross Road,Maranhalli, JP Nagar IInd Phase, Bangalore
St. Johns college and hospital, Sarjapur Road, Bangalore.
Medwin Hospitals,Chirag Ali Lane,Hyderabad
Sterling Hospital,Sterling Hospital Road, Mem Nagar,Ahmedabad
Amrita Institute of Medical Sciences and Research Center, Amrita Lane, Elamakkara PO, Cochin, Kerala
Months M.S. Ramaiah Memorial Hospital
St.John's medical College and Hospital
Mediheights Healthcare Pvt Ltd
2 Years S C B Medical college
Medical college Hospital
madras medical college
All India Institute of Medical Sciences (AIIMS)
Months Chanre Rheumatology & Immunology Centre & Research (CRIC&R)
Center For Rheumatic Diseases
L T M Medical College & L T M G Hospital
Institute of Post Graduate Medical Education & Research
Months M S Ramaiah Memorial Hospital
Years Balaji Clinic, Main Road, Devipada, Borivali (E)
169, Parvati gaon, Bhagirathi Medical Foundation
Pungaliya Hospital, opp veer savarkar bhavan, Shivaji Nagar
Sector 27 A/150, Nigadi pradhikaran
6
6 CARE Hospital
2
1
21
8
1 Mittal Hospital
8
4
Lady Ratan Tata Medical Research Center
Bhagwan Hahavir Jain Hospital
Instride Research Institute
Dr. V Seshiah Diabetes Care and Research Institute
2 Years Spandan Heart Institute and Research Center
Avanti Institute of Cardiology
Shri Ram Cardiac Center
26 Weeks Months
Swamy Diabetes Centre
Jothydev Diabetes and Research Centre
4 Months Diabetic clinic OP,Thiruvananthapuram medical college
Years Sri Ramachandra medical College, Chennai
Vijaya Health Centre, Chennai
Nizams Institute of Medical Sceinces, Hyderabad
CARE hospital, Hyderabad
24 Months Postgraduate Institute of Medical Education & Research,Sector 12, Chandigarh 160 012
Belgaum Diabetes Center,2nd Floor, Maruti Galli,Belgaum 590 001
Department of Endocrinology,diabetes and Metabolism ,Christian Medical College Hospital,
Bangalore Diabetes Hospital, No 16/M Thimmaiah Road, Miller Tank Bed Area, Vasanthnagar,
3 Months
Months M. S. Ramaiah Hospital
Diabetes Thyroid Hormone Research Institute
Dr. V Seshiah Diabetes Care and Research Institute - Department of Endocrinology
Department of Endocrinology, Bhagwan Mahaveer Jain Hospital
Years Belgaum Diabetes Centre
Bhagwan Mahavir Jain Hospital
Bharti Research Institute of Diabetes and Endocrinology
IRL Research Centre
19 Kasturba Hospital
1
3
4
6 S.R. Kalla Hospital
13 Ruby Hall Clinic Bharti Hospital
3
9
8
168-175 Days Diacon Hospital Diabetes care & Research Center
V Seshiah Diabetics Care and Research Center
Jnana Sanjeevani Medical Center
Months Diabetes OPD Sassoon Hospital
8 Months Bankers Heart Institute
Department Of Cardiology, Sri Venkateswara Institute Of Medical Sciences
Department Of Cardiology, MediCiti Hospital,
Months Eye Research Center & Retina Foundation
Dr. Rajendra Prasad Centre for Ophthalmic Sciences,All India Institute of Medical Sciences
Vittala International Institute of Ophthalmology
L.V. Prasad Eye Institute
Gujarat Endocrine Center
Coimbatore Diabetes Foundation
Diabetes Thyroid Hormone Research Institute
20 Months Diabetes Thyroid Hormone Research Institute Pvt. Ltd.
Bangalore Diabetes Hospital
56 Days Jnana sanjeevini diabetes center
samatvam : endocrinology diabetes center
Endocrinology Diabetes Centre
2 Years Baroda Heart Institute & Research Center, Vadodara
Government Medical College & Super Speciality Hospital, Nagpur
Arneja Heart Institute, Nagpur
Bankers Heart Institute, Vadodara
3 Years Chowpatty Medical Centre
Bhagwan Mahaveer Jain Hospital
Diabetes Thyroid Hormone Research Institute
King Edward Memorial Hospital
14
8
10 CARE Hospitals Bhatia Hospital Shivam Clinic
7
25
1
13
5
1
9
Gujarat Endocrine Center
Diabetes Thyroid Hormone Research Institute
Jawaharlal Nehru Medical College
The Bangalore Diabetes Hospital
Years Gokula Metropolis Clinical Research Center, M. S. Ramaiah Memorial Hospital,
Dande Diabetes and Heart Care,
Bangalore Diabetes Centre
Madras Diabetes Research Foundation
3 Years Pitale's Clinic, Diabetes and hormone centre
10 Months Dande Diabetes & Heart Care Centre
Pravara Institute of Medical Sciences
Dhanwantari Hospita
Joshi Hospital, Maharashtra Medical Society
3 Years Suyash Hospital Pvt Ltd
St. John's Medical College Department of Endocrinology
Aware Global hospital, Hyderabad
Pallakad diabetic Center
6 Months Consultant Physician & Diabetologist
Months Le Bonheur Endocrine & Diabetes Clinic
Pai Clinic & Diagnostic Centre
DHL Research Centre,
Sudeep Diabetes Care Centre,
8 Months Aravind Eye Hospital
Aravind Eye Hospital
National institute of Ophthalmology
Convest Jain clinic group of hospitals
Months Department Of Pediatrics,LLRM Medical College,Meerut(U.P),INDIA
15 Months Jain Institute of Vascular Sciences,
Dr. V Seshiah Diabetes Research Institute
Sir Ganga Ram Hospital,
S.K Diabetes & research Center
10 Medwin Hospital Diabetomics
5
1
1
10
12
1
Years Trichy Diabetic Speciality Center
Research Health Institute in Diabetes, Endocrinology & Metabolism (RHIDEM)
Years Fortis Flt Lt Rajan Dhal Hospital
Jnana Sanjeevini Medical Center
Diabetes Thyroid Hormone Research Institute (DTHRI)
INSTITUTE OF CLINICAL ENDOCRINOLOGY AND DIABETES CARE UNIT
Months Jyoti Clinical & Pathological Laboratory
6 Months Frontier Lifeline Pvt.Ltd
1 Months Bangalore Endocrinology and Diabetes Research Centre
Diabetes Thyroid Hormone Research Institute Pvt. Ltd.
Diabetes Care and Research Centre
Krishna Diabetes Clinic and Educational Research Centre
Years Amrita Institute of Medical Sciences
Bangalore Diabetes Hospital
Madras Diabetes Research Foundation
Health and Research Centre
3 Months Jyoti Clinical & Pathological Laboratory
Site 5 Site 6 Site 7 Site 8 Site 9
Medwin hospitals, Lotus DiagnosticsInstitute of Post Graduate Medical Education & Research and SSKM Hospital
M V Hospital for Diabetes and Diabetic Research Center
All India Institute of Medical Sciences
Arthur Asirvatham Hospital
Dr. V Seshiah Diabetes Care
Diabetes Care & Research Centre,
Cuttack Diabetes Research Foundation,
Rama Krishna Mission Seva Prathisthan
Advance Eye Center Retina FoundationLittle Flower Hospital Trust
Aditya Jyot Eye Hospital
Regional Institute Of Ophthalmlogy
Post Graduate Institute of Medical Sciences
Mahatma Gandhi Institute of Medical Sciences
KEM Hospital & Seth G.S Medical College
Life Worth Super Speciality Hospital
Baby Memorial Hospital
DiabetOmics India.
Apollo Hospital SRMC
Diabetes Thyroid Hormone Research Institute Pvt. Ltd.
Bharti Research Institute of Diabetes and Research
Medilink Research Centre
All India Institute of Diabetes & Research
Belgaum Diabetes Hospital,Ground floor, Maruthigalli,Belgaum
Bangalore Diabetes Hospital,LNo 16/M,Thimmaiah Road,Vasanthnagar Bangalore
Mediheights Health Care Private Limited, Opp Ajanta Pharma,Hindustan Naka, Kandivli West, Mumbai
Dr.V.Seshiah Diabetes Care& Research Institute,No.31 A, Ormes Road, Kilpauk,Chennai
Endocrinology Diabetes Centre,640 First main First Stage Indiranagar,Bangalore
JSS Medical College Hospital
Postgraduate Institute of Medical Education & Research
Madras Diabetes Research Foundation
Shri Ramachandra Medical College & Research Institute
St. John's Medical College Hospital
Nizam's Institute of Medical Sciences
Krishna Institute of Medical Sciences
BYL Nair Charitable Hospital,
Shubhechha Multispecialty Hospital
Owaisi Hospital and Research Centre
Amrita Institute of Medical Sciences
Shubhechha Multispeciality Hospital
INSTRIDE, 6 poonam arcade,1170/11 revenue colony, J.M Road Shivaji Nagar,
Behind Hotel Vasco, Nasik Road
Cosmopolitan Medical Care Center
Associates in Clinical Endocrinology Education and Research
Deenanath Mangeshkar Hospital and Research Centre
Amrita Institute of Medical Sciences
Owasis Hospital & Research Center, Hyderabad
J.S.S.hospital, Mysore
St. John's Medical College and Hospital, Bangalore
M.S.Ramaiah Memorial Hospital, Bangalore
Kovai Medical Centre and Hospital, Coimbatore
Diabetes Unit,KEM Hospital Research Center,6th Floor Banoo Coyaji Bldg,Sardar Moodliar Road,
Department of Endocrinology and Metabolism,Room # 311, 3rd Floor ,AIIMS,New Delhi - 110029
Diabetomics India,6-3-349/ 17B ,Hindi Nagar,Banjara hills PO,Hyderabad- 500034
Orange Diabetes Specialty Clinic
K.G.N. Diabetes and Endocrine Centre
Pitale Diabetes and Hormone Centre
Department of Endocrinology, Jawaharlal Nehru Medical College and Hospital
B.P Poddar Hospital and Medical Research
Bangalore Diabetes Hospital
S.R Kalla Memorial Gastro and General Hospital
Dande Diabetes & Heart Care Centre,
Diabetes Care & Research Centre,
The Bangalore Diabetes Hospital
Bangalore Endocrinology and Diabetes Research Centre
Amrita Institute of Medical Sciences
Medisys Clinisearch India Pvt Ltd.
Diabetes Care & Research Institute
Jnana Sanjeevini Medical Center
Lotus Diagnostic Centre
CHL Apollo Hospitals, Indore.
Sri Ramakrishna Heart Foundation & Research Centre, Coimbatore
CHL Apollo Hospitals, Indore.
CHL Apollo Hospitals, Indore.
CHL Apollo Hospitals, Indore.
Bharti Research Institute of Diabetes and Endocrinology (BRIDE), Bharti Hospital
Bangalore Diabetes Centre
Mediheights Health Care Pvt Ltd
Samatvam, Science & Research for Human Welfare Trust
Care Hospital
KEM Hospital
Endocare Clinic ACEER
Akshay Hospital
D,Clinarch Diabetomics
Shroff Eye Hospital
Patil Hospital
King Edward VII Memorial Hospital
M S Ramaiah Medical College Hospital
Health and Research Centre
Banaras Hindu University
Madras Diabetes Research Foundation
Diabetes Care and Research Centre
M.V. Hospital For Diabetes Pvt. Ltd.
Diabetes Care and Research Centre
Medisys Clinisearch India Pvt. Ltd. (Bangalore Diabetes centre)
Bhagawan Mahaveer Jain Hospital
Poona Hospital & Research Center
J. N. Medical College, KLE Hospital & Research Center
Department of Medicine
Sai Venketeshwara hospital
Padmasree Diagnostics
Standard Laboratory and Polyclinic
Aruna Diabetes Centre
Post-Graduate Institute of Medical Education & Research (PGIMER)
B.J. Medical College & Civil Hospital,
HCG Medisurge Hospital
Karnataka Institute of Diabetology
St. John's Medical College & Hospital
MV Hospital for Diabetes Pvt Ltd
Om shree Swami samarth hospital
Endocare Clinic
Krishna Diabetes Clinic and Educational Research Centre
Bangalore Endocrinology and Diabetes Research Center (BEDRC)
Belgaum Diabetes Centre
Diabetes Care & Research Center
Bangalore Diabetes Centre
GOVT MEDICAL COLLEGE
Medisys Clinisearch India Pvt. Ltd.
Bharti Research Institute of Diabetes and Endocrinology
Belgaum Diabetes Centre
Research Health Institute in Diabetes
Jnana Sanjeevini Medical Center
Nizam?s institute of Medical Sciences
Pitale Diabetes & Hormone centre
Samatvam: Endocrinology Diabetes Centre
S.R Kalla Memorial Hospital
Site 10 Site 11 Site 12 Site 13 Site 14
Park Clinic
M S Ramaiah Memorial Hospital
St.Johns Medical College
Kasturba Medical College
Dr V Seshiah Diabetes Care and Research Institute,
Amrita Institute of Medical Sciences and Research Centre
Apollo Gleneagles Hospitals Ltd
Manipal Acunova Clinical Research Centre (Manipal Hospital)
Medilink Research Basement
P.D. Hinduja National Hospital & Research Center
Narayana Netralaya
P.S.G Hospital Care Hospital
Vision Research Foundation
L.V. Prasad Eye Institute
L.V. Prasad Eye Institute
Dr. Shroff?s Charity Eye Hospital
Avanti Institute of Cardiology Pvt.Ltd
Assam MEdocal College & Hospital
Dr. B.R. Patel Hospital
Nizam's Institute of Medical Sciences, Dept of Endocrinology and Metabolism, Punjagutta,Hyderabad
Mediciti Hospital, 5-9-22, Secretariat Road,Hyderabad
KEM Hospital,Sardar Moodliar Road,Pune
Diabetes Clinic and Research Centre,Shreeniwas Opp Dhantoli Park,Nagpur
Apollo Hospitals International Limited, Ahm-1A, Bhat GIDC Estate-Ahmedabad
Dr V Seshiah Diabetes Care and Research Institute
Health and Research Center
Gandhi Research Institute
BYL Nair Ch. Hospital
JNANA SANJEEVINI MEDICAL CENTER
Sparsh Orthopaedic Hospital
Brain and Mind Institute, Nagpur
Neuro Care Centre, Lucknow
Baby Memorial Hospital, Calicut
Mallikatta Neuro and Research Centre, Mangalore
Deenanath Mangeshkar Hospital and Reserch center, Pune
K G Hospital Sterling Hospital
St. John Medical College Hospital,
Deenanath Mangeshkar Hospital and Research Centre
Sunil's Diabetic Care and Research Centre
Research Health Institute in Diabetes,
Health and Research Centre,
Diabetes Unit 6TH Floor
Nizam's Institute of Medical Sciences
DIACARE
Rudrawadi Hospital
Mediciti Hospital Global Hospitals Medwin Hospitals
Dia-care Clinic
IPGMER and SSKM Hospital
Dr Vaishnavas Diabetes Clinic
Diabetes Care and Research Centre
Hormone Care and Research Centre
Department of Medicine
Trichy Diabetes Speciality Center (P) Ltd
Bangalore Endocrinology and Diabetes Centre
St. John?s Medical College & Hospital
Bharti research institute of Diabetes and Endocrinology
Sunil's Diabetes care and Research Centre
Gokula Metropolis Clinical Research Centre
King George Hospital
Diabetes Thyroid Hormone Research Institute
Site 15 Site 16 Site 17 Site 18 Site 19
KEM Hospital Mediciti Hospitals Care Hospital Nizams Institute of Medical Sciences
Osmania General Hospital
Orange Diabetes Speciality Clinic
Prince Aly Khan Hospital,
Endocrine and Diabetes Centre
All India Institute of Medical Sciences
Hormone Care Centre
Shroff Eye Hospital
Shreenath Hospital Krishna Institute of Medical Sciences Ltd
Dept of Medicine, JSS Medical College Hospital ,Ramanuja Road, Agrahara, Mysore
Fortis Escorts Hospital
Dayanand Medical college & hospital, Ludhiana
Apollo Hospitals, Hyderabad
Neurology Centre , Ahemdabad
Ruby General Hospital, Kolkata
Pankaj Gupta Clinic, Jaipur
Apollo Hospital,Indraprastha Apollo Hospital
Apollo Speciality Hospital
Diabetologist Spectra Research Clinical Centre,
Krishna Diabetes Clinic and Educational Research Centre,
ACEERCoimbatore Diabetes Foundation
Health and Research Division
Department of Medicine
Hubli Clinical research Center
Site 20 Site 21 Site 22 Site 23 Site 24
Mediciti Hospitals Medwin Hospitals
Life care Institue of Medical Sciences & Research
Pushpawati Singhania Research Institute
Diabetes, Thyroid and Endocrine Centre
Krishna Institute of medical sciences Ltd
Diacon Hospital and Research Centre
Moses Diabetes and Medical Center
Sunil's Diabetes Care Research
Sunil's Diabetes Care Research
Site 25
Mediheights Healthcare Private Limited